CA3198533A1 - Nicotine pouch composition - Google Patents

Nicotine pouch composition

Info

Publication number
CA3198533A1
CA3198533A1 CA3198533A CA3198533A CA3198533A1 CA 3198533 A1 CA3198533 A1 CA 3198533A1 CA 3198533 A CA3198533 A CA 3198533A CA 3198533 A CA3198533 A CA 3198533A CA 3198533 A1 CA3198533 A1 CA 3198533A1
Authority
CA
Canada
Prior art keywords
nicotine
pouch
weight
pouch composition
fibers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3198533A
Other languages
French (fr)
Inventor
Kent Albin Nielsen
Jessie POULSEN
My Ly Lao STAHL
Bine Hare JAKOBSEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philip Morris Products SA
Original Assignee
Philip Morris Products SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20207822.6A external-priority patent/EP4000424B1/en
Priority claimed from US17/099,446 external-priority patent/US20220151292A1/en
Application filed by Philip Morris Products SA filed Critical Philip Morris Products SA
Publication of CA3198533A1 publication Critical patent/CA3198533A1/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10Chemical features of tobacco products or tobacco substitutes
    • A24B15/16Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B13/00Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/28Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/42Treatment of tobacco products or tobacco substitutes by chemical substances by organic and inorganic substances

Abstract

A pouch composition is disclosed, the pouch composition comprising a nicotine-ion exchange resin combination, water in an amount of at least 15% by weight of the pouch composition, and inorganic divalent cations. Also, an oral pouched nicotine product comprising a saliva-permeable pouch and the pouch composition in said pouch and a pouch composition is disclosed.

Description

PCT/D1(2021/050334 NICOTINE POUCH COMPOSITION
FIELD OF INVENTION
The present invention relates to pouch compositions and an oral pouched nicotine product according to the claims.
BACKGROUND
Delivery of nicotine by smoking has many well-known drawbacks, in particular health related problems, such as inclusion of carcinogenic substances.
However, tobacco substitutes also suffer from disadvantages, such as inadequate relief of cravings for the user.
A further challenge in the prior art is that the desired release of nicotine should be attractive to the user of the pouch from a user perspective.
Yet at further challenge in relation to the prior art may be that pouches as delivery vehicle for nicotine may be somewhat costly and thereby impose restrictions on the way pouches are designed in order to keep manufacturing costs in check.
It is an object of one embodiment of the present invention to provide a nicotine containing pouch, e.g. as a tobacco substitute, which may solve the above problems.
SUMMARY
The present invention relates to a pouch composition comprising a nicotine-ion exchange resin combination, water in an amount of at least 15% by weight of the pouch composition, and inorganic divalent cations.
One advantage of the present invention may be that a relatively high stability of the provided nicotine may be obtained, while at the same time obtaining a relatively fast PCT/D1(2021/050334
2 nicotine release. Obtaining a high stability may lead to nicotine being bound too effectively e.g. to a carrier and therefore lead to slow release. By means of the claimed pouch composition, including combination of a water content of at least 15% by weight of the composition and divalent inorganic cations, a high stability yet fast release is facilitated, while also having a very desirable mouthfeel and taste. The high water content facilitates effective release of nicotine during use.
One advantage of the invention is that a relatively fast release rate of nicotine from the pouch composition may be obtained due to the presence of the divalent cations.
At the same time a desirable moist mouthfeel is provided, due to the high water content, which also facilitate fast nicotine release.
Furthermore, the invention may advantageously provide a more effective release of nicotine during use of a pouch comprising the pouch composition. Obtaining an effective release of nicotine may enable a lower total dose of nicotine with the same amount of nicotine released, due to a minimization of any residual nicotine not released from the pouch composition.
In an advantageous embodiment of the invention, the solid oral nicotine formulation comprises inorganic divalent cations in molar ratio of at least 0.1 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at least 0.25 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at least 0.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
In an advantageous embodiment of the invention, the pouch composition comprises inorganic divalent cations in molar ratio of at least 0.1 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at least 0.25 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at least 0.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination.

PCT/D1(2021/050334
3 The amount of divalent cations should advantageously be high enough to enable ion-exchange of the complexed nicotine for the divalent cations during use of a pouch comprising the pouch composition.
Furthermore, the amount of inorganic divalent cations may advantageously also decrease the probability of exchanged nicotine from re-complexing with the ion-exchange resin, simply by occupying binding sites on the ion-exchange resin during use.
In an embodiment of the invention the amount of inorganic divalent cations may even prevent exchanged nicotine from re-complexing with the ion-exchange resin during use.
Also, the amount of inorganic divalent cations may decrease the probability of any un-complexed nicotine, such as free base nicotine and/or exchanged nicotine from complexing/re-complexing with the ion-exchange resin during use.
In an advantageous embodiment of the invention, the solid oral nicotine formulation comprises inorganic divalent cations in a molar ratio of at most 6.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 6 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 3.75 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 2.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
In an advantageous embodiment of the invention, the pouch composition comprises inorganic divalent cations in a molar ratio of at most 5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 3.75 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such PCT/D1(2021/050334
4 as at most 2.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
One advantage of the above embodiment may be that including inorganic divalent cations in a not too high amount facilitates a desirable taste and mouthfeel, by avoiding or minimizing undesirable taste and/or mouthfeel, such as undesired salty taste, a local dehydration or even an oral dehydrating sensation.
In an embodiment of the invention the pouch composition comprises inorganic divalent cations in a molar ratio of between 0.1 and 6.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as 0.1 and 6.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as 0.1 and 5.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 4.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 3.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 2.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 1.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
In an embodiment of the invention the pouch composition comprises inorganic divalent cations in a molar ratio of between 0.1 and 5.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.5 and 5.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.75 and 5.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 1.0 and 4.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 2.0 and 4.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
In an embodiment of the invention the pouch composition comprises inorganic divalent cations in a molar ratio of between 0.01 and 5.0 relative to the amount of
5 PCT/D1(2021/050334 nicotine in the nicotine-ion exchange resin combination, such as between 0.01 and 4.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.01 and 3.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.01 and 2.0 relative to the amount of nicotine in 5 the nicotine-ion exchange resin combination, such as between 0.01 and 1.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
Here, the molar ratio refers to the molar content of divalent cations divided by the molar content of nicotine.
In an advantageous embodiment of the invention, the inorganic divalent cations are selected from the group consisting of divalent cations of calcium, magnesium, iron, zinc, and any combination thereof.
In an advantageous embodiment of the invention, the inorganic divalent cations are selected from the group consisting of divalent cations of calcium and magnesium.
In an embodiment of the invention, the inorganic divalent cations are provided as a salt comprising inorganic or organic anions.
In an advantageous embodiment of the invention, the inorganic divalent cations are provided as a salt comprising anions selected from the group consisting of carboxylates, such as acetate, lactate, oxalate, propionate, or levulinate, organic sulfonate, organic sulfate, organic phosphate, chloride, bromide, nitrate , sulfate, hydrogen phosphate, oxide, and any combination thereof.
In an embodiment of the invention the inorganic divalent cations are provided as a salt in an amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0% by weight of the composition.

PCT/D1(2021/050334
6 In an embodiment of the invention, the organic anions are selected from the group consisting of carboxylates, such as acetate, lactate, oxalate, propionate, levulinate;
organic sulfonate; organic sulfate; organic phosphate; and any combination thereof In an advantageous embodiment of the invention, the inorganic divalent cations are provided as an inorganic salt.
In an advantageous embodiment of the invention, the inorganic divalent cations are provided as an inorganic salt in an amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0% by weight of the composition.
In an embodiment of the invention the inorganic divalent cations are provided as an inorganic salt in the amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0% by weight of the composition.
In an embodiment of the invention the inorganic divalent cations are provided as an inorganic salt in the amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and
7.0% by weight of the composition, such as between 0.1 and 7.0% by weight of the composition, such as between 0.5 and 5.00/0 by weight of the composition, such as between 0.5 and 4.0% by weight of the composition.
In an advantageous embodiment of the invention, inorganic divalent cations are provided as an inorganic salt comprising inorganic anions selected from the group consisting of chloride, bromide, nitrate, sulfate, hydrogen carbonate, hydrogen phosphate, oxide, hydroxide, and any combination thereof PCT/D1(2021/050334 It is noted that in some embodiments, the inorganic anions may be combined e.g. such that the cations form separate salts with two different types of anions. One example could e.g. be magnesium chloride combined with magnesium bromide.
In an advantageous embodiment of the invention, wherein the inorganic divalent cations are provided as an inorganic salt comprising inorganic anions are selected from the group consisting of chloride, bromide, sulfate, hydrogen carbonate, and any combination thereof.
In an advantageous embodiment of the invention, wherein the inorganic divalent cations are provided as an inorganic salt comprising inorganic anions are selected from the group consisting of chloride, bromide, sulfate, and any combination thereof In an advantageous embodiment of the invention, wherein the inorganic divalent cations are provided as an inorganic salt comprising inorganic anions are selected from the group consisting of chloride, bromide, and any combination thereof In an advantageous embodiment of the invention, the inorganic anions comprise chloride.
In an embodiment of the invention, the inorganic cations are magnesium and/or calcium and the anions comprise chloride.
In an embodiment of the invention, the inorganic anions are chloride.
In an embodiment of the invention, the inorganic cations are magnesium and/or calcium and the anions are chloride.
In an advantageous embodiment of the invention, the inorganic divalent cations are provided as an inorganic salt selected from the group consisting of calcium chloride or magnesium chloride, or combinations thereof PCT/D1(2021/050334
8 In an embodiment of the invention, the divalent cations are provided as a pharmaceutically acceptable salt.
In an embodiment of the invention, the divalent cations are provided as a pharmaceutically acceptable inorganic salt.
In an embodiment of the invention the inorganic divalent cations are provided as a hydrated salt.
In an embodiment of the invention the inorganic divalent cations are provided as a hydrated inorganic salt.
In an embodiment of the invention, the divalent cations are provided as an alimentary acceptable salt.
In an embodiment of the invention, the divalent cations are provided as an alimentary acceptable inorganic salt.
In an advantageous embodiment of the invention, the divalent cations are provided as a water-soluble salt having a water-solubility of at least 5 gram per 100 mL
of water measured at 25 degrees Celsius, atmospheric pressure and pH 7Ø
With atmospheric pressure is understood a pressure around 101.3 1cPa or a pressure within the range of 90 to 110 kPa.
In an embodiment of the invention the pouch composition comprises inorganic divalent cations provided as a water-soluble salt, wherein the pouch composition comprises said inorganic divalent cations provided as a water-soluble salt in a molar ratio of between 0.1 and 6.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as 0.1 and 6.0 relative to the amount of nicotine in PCT/D1(2021/050334
9 the nicotine-ion exchange resin combination, such as 0.1 and 5.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 4.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 3.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 2.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 1.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
In an embodiment of the invention the inorganic divalent cations are provided as a water-soluble salt in the amount of between 0.1 and 15.0% by weight of the composition.
In an embodiment of the invention, the divalent cations are provided as an inorganic and water-soluble salt having a water-solubility of at least 5 gram per 100 mL
of water measured at 25 degrees Celsius, atmospheric pressure and pH 7Ø
In an embodiment of the invention the inorganic divalent cations are provided as a water-soluble salt in the amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 7.0% by weight of the composition, such as between 0.1 and 7.0% by weight of the composition, such as between 0.5 and 5.0% by weight of the composition, such as between 0.5 and 4.0% by weight of the composition.
In an embodiment of the invention the pouch composition comprises inorganic divalent cations provided as an inorganic, water-soluble salt, wherein the pouch composition comprises said inorganic divalent cations provided as an inorganic, water-soluble salt in a molar ratio of between 0.1 and 6.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as 0.1 and 6.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as 0.1 and 5.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 4.0 relative to the amount of nicotine in the nicotine-ion exchange PCT/D1(2021/050334 resin combination, such as between 0.1 and 3.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 2.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as between 0.1 and 1.0 relative to the amount of nicotine in the nicotine-ion exchange 5 resin combination.
In an embodiment of the invention the inorganic divalent cations are provided as an inorganic and water-soluble salt in the amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such
10 as between 0.5 and 7.0% by weight of the composition, such as between 0.1 and 7.0%
by weight of the composition, such as between 0.5 and 5.0% by weight of the composition, such as between 0.5 and 4.0% by weight of the composition.
With provided is here understood, that the inorganic cations are added to the composition as a salt.
By providing the divalent cations as a water-soluble salt, the dissolution of the salt into cations could advantageously be faster and more effective, whereby relative fast release of nicotine could be achieved.
In an advantageous embodiment of the invention, the pouch composition comprises nicotine in an amount of at least 0.1% by weight, such as least 0.2% by weight of the pouch composition.
In an embodiment of the invention, the pouch composition comprises nicotine in an amount of 0.1 to 5.0% by weight of the pouch composition, such as 0.2 to 4.0%
by weight of the pouch composition, such as 1.0 to 2.0% by weight of the pouch composition.

PCT/D1(2021/050334
11 The pouch composition should have a desirable content of nicotine able to provide the user with a desirable dose of nicotine, while also providing the user with a desirable volume of composition being enclosed in the pouch.
In an advantageous embodiment of the invention, the pouch composition comprises nicotine-ion exchange combination in an amount of 0.1 to 20% by weight of the pouch composition.
It is understood here, that the divalent cations does not form part of the nicotine-ion exchange combination when preparing the pouch composition. If combined before preparation of the pouch composition. A pre-combination may cause stability issues, since the divalent cations could induce a too early release of nicotine from the ion-exchange resin. This could in particular be a problem, when incorporating a such combination into a pouch composition having a high water content, such as at least 15% by weight of the pouch composition.
In an embodiment of the invention, the divalent cations are not included in the provided nicotine-ion-exchange combination.
In an embodiment of the invention, the nicotine-ion-exchange combination does not comprise divalent cations.
In an embodiment of the invention, the divalent cations are provided as a salt.
In an embodiment of the invention, the pouch composition comprises nicotine-ion exchange combination in an amount of 0.1 to 20% by weight of the pouch composition, such as 1.0 to 15% by weight of the pouch composition, such as 3.0 to 15% by weight of the pouch composition, such as 5.0 to 15% by weight of the pouch composition.
In an embodiment of the invention, the pouch composition comprises nicotine-ion exchange combination in an amount of 0.1 to 20% by weight of the pouch composition, PCT/D1(2021/050334
12 such as 1.0 to 15% by weight of the pouch composition, such as 1.0 to 10% by weight of the pouch composition, such as 3.0 to 10% by weight of the pouch composition.
In an advantageous embodiment of the invention, the nicotine-ion exchange resin combination comprises nicotine in an amount of between 5 and 50% by weight.
In an embodiment of the invention the nicotine-ion exchange resin combination comprises nicotine complexed with ion exchange resin, wherein the nicotine constitutes an amount of between 5 and 50% by weight of nicotine-ion exchange resin combination.
In an embodiment of the invention the nicotine-ion exchange resin combination consists of nicotine complexed with ion exchange resin, wherein the nicotine constitutes an amount of between 10 and 50% by weight of nicotine-ion exchange resin combination, such as between 10 and 40% by weight of nicotine-ion exchange resin combination, such as. between 10 and 30% by weight of nicotine-ion exchange resin combination, such as between 10 and 25% by weight of nicotine-ion exchange resin combination.
In an embodiment of the invention the nicotine-ion exchange resin combination comprises free-base nicotine mixed with ion exchange resin, wherein the nicotine constitutes an amount of between 5 and 50% by weight of nicotine-ion exchange resin combination.
In an embodiment of the invention the nicotine-ion exchange resin combination comprises free-base nicotine mixed with ion exchange resin, wherein the nicotine constitutes an amount of between 5 and 50% by weight of nicotine-ion exchange resin combination, such as between 10 and 50% by weight of nicotine-ion exchange resin combination, such as between 20 and 50% by weight of nicotine-ion exchange resin combination, such as between 25 and 50% by weight of nicotine-ion exchange resin PCT/D1(2021/050334
13 combination, such as between 25 and 45% by weight of nicotine-ion exchange resin combination.
In an embodiment of the invention the nicotine-ion exchange resin combination comprises free-base nicotine mixed with ion exchange resin, wherein the nicotine constitutes an amount of between 5 and 40% by weight of nicotine-ion exchange resin combination, such as between 10 and 40% by weight of nicotine-ion exchange resin combination, such as between 10 and 35% by weight of nicotine-ion exchange resin combination, such as between 10 and 25% by weight of nicotine-ion exchange resin combination, such as between 10 and 15% by weight of nicotine-ion exchange resin combination.
In an advantageous embodiment of the invention, the nicotine-ion exchange resin combination comprises nicotine in an amount of between 5 and 50% by weight and ion-exchange resin in an amount between 10 and 95% by weight.
In an embodiment of the invention the nicotine-ion exchange resin combination comprises nicotine in an amount of between 5 and 50% by weight and ion-exchange resin in an amount between 10 and 95% by weight.
In an embodiment of the invention the nicotine-ion exchange resin combination comprises nicotine in an amount of between 10 and 30% by weight and ion-exchange resin in an amount between 20 and 90% by weight.
In an embodiment of the invention the nicotine-ion exchange resin combination consist of nicotine in an amount of between 10 and 30% by weight and ion-exchange resin in an amount between 70 and 90% by weight.
In an embodiment of the invention the nicotine-ion exchange resin combination is substantially free of water.

PCT/D1(2021/050334
14 In an embodiment of the invention the nicotine-ion exchange resin combination further comprising a C3 sugar alcohol.
In an embodiment, the C3 sugar alcohol may be selected from glycerol, propylene glycol, and any combination thereof.
In an embodiment of the invention the nicotine-ion exchange resin combination further comprises glycerol.
In an embodiment of the invention, the nicotine-ion exchange resin combination further comprises glycerol in an amount of 0.1 to 50% by weight, such as 5 to 40% by weight, such as 5 to 30% by weight.
In an embodiment of the invention the nicotine-ion exchange resin combination comprises nicotine in an amount of between 5 and 50% by weight and ion-exchange resin in an amount between 20 and 75% by weight.
In an embodiment of the invention the nicotine-ion exchange resin combination comprises water in an amount of no more than 75% by weight, such as no more than 50% by weight, such as no more than 40% by weight, such as no more than 30% by weight, such as no more than 20% by weight, such as no more than 10% by weight, such as no more than 5% by weight.
In an advantageous embodiment of the invention, the ion exchange resin comprises one or more resin(s) selected from the group consisting of:
(i) a methacrylic, weakly acidic type of resin containing carboxylic functional groups, (ii) a copolymer of methacrylic acid and divinylbenzene, said copolymer containing carboxylic functional groups, (iii) a polystyrene, strongly acidic type of resin containing sulphonic functional groups, (iv) a polystyrene, intermediate acidic type of resin containing phosphonic functional groups, and PCT/D1(2021/050334 (v) a combination thereof.
In an advantageous embodiment of the invention, the ion exchange resin comprises polacrilex resin.

In an advantageous embodiment of the invention, the ion exchange resin is polacrilex resin.
In an embodiment of the invention, the ion exchange resin is polacrilex resin.
In an embodiment of the invention, the polacrilex resin comprises or is AmberlitegIRP64.
In an advantageous embodiment of the invention, the nicotine-ion exchange resin combination comprises nicotine complexed with ion exchange resin.
In an advantageous embodiment of the invention, the nicotine-ion exchange resin combination is nicotine complexed with ion exchange resin.
Thus, in the above embodiment the nicotine-ion exchange resin combination consists of nicotine complexed with ion exchange resin.
In an advantageous embodiment of the invention, the nicotine-ion exchange resin combination comprises free-base nicotine mixed with ion exchange resin.
One advantage of the above embodiment may be providing sustained release of nicotine. At the same time, the release rate of nicotine is not too slow to give the user the craving relief desired.
In an embodiment of the invention, the nicotine-ion exchange resin combination is free-base nicotine mixed with ion exchange resin.

PCT/D1(2021/050334 In an embodiment of the invention the pouch composition comprises further nicotine.
In an embodiment of the invention the pouch composition comprises further nicotine.
In an embodiment of the invention the pouch composition comprises further nicotine selected from the group consisting of a nicotine salt, nicotine free base, nicotine bound to an ion exchanger, such as an ion exchange resin, such as nicotine polacrilex resin, a nicotine inclusion complex or nicotine in any non-covalent binding; nicotine bound to zeolites; nicotine bound to cellulose, such as microcrystalline cellulose, or starch microspheres, and mixtures thereof.
In an advantageous embodiment of the invention, the pouch composition comprises water in an amount of 15-65% by weight of the composition, such as 15-60% by weight of the composition, such as 15-50% by weight of the composition, such as 20-50% by weight of the composition, such as 20-40% by weight of the composition, such as 25-40% by weight of the composition, such as 25-35% % by weight of the composition.
In an embodiment of the invention, the pouch composition comprises water in an amount of 15-65% by weight of the composition, such as 20-65% by weight of the composition, such as 25-65% by weight of the composition.
In an embodiment of the invention, the pouch composition comprises water in an amount of 15-65% by weight of the composition, such as 15-60% by weight of the composition, such as 15-50% by weight of the composition, such as 15-40% by weight of the composition.
In an embodiment of the invention, the pouch composition comprises water in an amount of 15-60% by weight of the composition, such as 15-50% by weight of the PCT/D1(2021/050334 composition, such as 15-40% by weight of the composition, such as 15-30% by weight of the composition.
In an embodiment of the invention, the pouch composition comprises water in an amount of 15-40% by weight of the composition.
The water may be added as a separate component to be fully or partly mixed into other components, such as fibers. E.g. when adding a nicotine ion-exchange combination consisting of a mixture of free base nicotine with ion exchange resin and water, a significant amount of water of the final pouch composition may come from the this mixture. For example, if the final amount pouch composition comprises 5% water from the nicotine-ion exchange resin combination, then up to one third of the water in the pouch composition derives from the nicotine-ion exchange resin combination.
In an advantageous embodiment of the invention, the pouch composition comprises at least one sugar alcohol.
In an embodiment of the invention, xylitol, maltitol, mannitol, erythritol, isomalt, sorbitol, lactitol, and mixtures thereof is used as the at least one sugar alcohol. The at least one sugar alcohol may also comprise further sugar alcohols. As an example embodiment, hydrogenated starch hydrolysates may be used, which comprises a mixture of sorbitol, maltitol and further sugar alcohols.
Sugar alcohols may advantageously facilitate and induce salivation of the pouch composition, whereby dissolution of the inorganic divalent cations are achieved, and release of nicotine is obtained, such as release of nicotine from the ion-exchange resin and release of nicotine from the pouch.
Sugar alcohols may advantageously be used to further increase the nicotine release from the pouch.

PCT/D1(2021/050334 Also, sugar alcohols may advantageously be used for obtaining a desirable mouthfeel by increasing salivation and thereby counteract any local dehydration or oral dehydrating sensation experienced by the user of the pouch.
Thus, sugar alcohol may advantageously be used in combination with inorganic divalent cations in order to achieve a desirable release of nicotine, while also a desirable taste is achieved.
In an embodiment of the invention, the at least one sugar alcohol is selected from sugar alcohols having at least 4 carbon atoms.
In an advantageous embodiment of the invention, the at least one sugar alcohol is selected from xylitol, maltitol, mannitol, erythritol, isomalt, sorbitol, lactitol, and mixtures thereof.
In an advantageous embodiment of the invention, the pouch composition comprises at least two sugar alcohols.
It is noted that different sugar alcohols may be applied for the purpose of taste and salivation, where the sugar alcohol composition is made of different sugar alcohols having different properties with respect to storage, bacteria growth, processability and/or taste.
In an embodiment of the invention, the at least two sugar alcohols are selected from xylitol, maltitol, mannitol, erythritol, isomalt, sorbitol, lactitol, and mixtures thereof.
In an advantageous embodiment of the invention, the pouch composition comprises sugar alcohol in an amount of at least 1% by weight of the composition, such as at least 2% by weight of the composition, such as at least 5% by weight of the composition, such as at least 10% by weight of the composition, such as at least 15%
by weight of the composition.

PCT/D1(2021/050334 In an advantageous embodiment of the invention, the pouch composition comprises sugar alcohol in an amount of 1 to 80% by weight of the composition, such as 2 to 700/0 by weight of the composition, such as 5 to 60% by weight of the composition, such as 10 to 50% by weight of the composition, such as 15 to 50% by weight of the composition.
In an embodiment of the pouch composition comprises sugar alcohol in an amount of 1 to 80% by weight of the composition, such as 2 to 70% by weight of the composition, such as 5 to 60% by weight of the composition, such as 10 to 50% by weight of the composition, such as 15 to 50% by weight of the composition.
In an embodiment of the pouch composition comprises sugar alcohol in an amount of 1 to 80% by weight of the composition, such as 10 to 70% by weight of the composition, such as 10 to 60% by weight of the composition, such as 15 to 60%
by weight of the composition, such as 20 to 60% by weight of the composition, such as to 50% by weight of the composition.
In an advantageous embodiment of the invention, the pouch composition comprises at 20 least one water-insoluble fiber.
In an advantageous embodiment of the invention, the pouch composition comprises said water-insoluble fiber in an amount between 5 and 50 % by weight of the pouch composition, such as 10-45% by weight of the pouch composition, such as 15-40%
by weight of the pouch composition.
In an embodiment of the invention, the pouch composition comprises said water-insoluble fiber in an amount between 5 and 50 % by weight of the pouch composition, such as 5-45% by weight of the pouch composition, such as 5-40% by weight of the pouch composition.

PCT/D1(2021/050334 In an embodiment of the invention, the pouch composition comprises said water-insoluble fiber in an amount between 5 and 50 % by weight of the pouch composition, such as 10-50% by weight of the pouch composition, such as 15-50% by weight of the pouch composition.

An advantage of the above embodiment may be that a residue is left even after use of a nicotine pouch comprising the pouch composition. This may lead to a pleasant perception for users of the nicotine pouch, e.g. due to similarity with tobacco containing products.
The water-insoluble fiber may advantageously provide a desirable mouthfeel throughout the use of the pouch.
In an advantageous embodiment of the invention, the water-insoluble fiber is a plant fiber.
In an advantageous embodiment of the invention, the water-insoluble fiber is selected from wheat fibers, pea fibers, rice fiber, maize fibers, oat fibers, tomato fibers, barley fibers, rye fibers, sugar beet fibers, buckwheat fibers, potato fibers, cellulose fibers, apple fibers, cocoa fibers, cellulose fibers, bran fibers, bamboo fibers, powdered cellulose, and combinations thereof.
Powdered cellulose within the scope of the invention is understood to be cellulose prepared by processing alpha-cellulose obtained as a pulp from strains of fibrous plant materials, such as wood pulp.
In an embodiment of the invention, the water-insoluble fiber comprises or consists of cereal fibers.
In an embodiment of the invention, the water-insoluble fiber comprises or consists of fruit and/or vegetable fibers.

PCT/D1(2021/050334 In an embodiment of the invention, the water-insoluble composition comprises or consists of water-insoluble fiber selected from wheat fibers, oat fibers, pea fibers, powdered cellulose, or combinations thereof.
In an embodiment of the invention, the water-insoluble fiber is selected from wheat fibers, oat fibers, pea fibers, powdered cellulose, or combinations thereof.
In an embodiment of the invention, the water-insoluble composition comprises or consists of water-insoluble fiber selected from wheat fibers, oat fibers, pea fibers, or combinations thereof.
In an embodiment of the invention, the water-insoluble fiber is selected from wheat fibers, oat fibers, pea fibers, or combinations thereof.
In an embodiment of the invention, the water-insoluble composition comprises or consists of water-insoluble fiber selected from wheat fibers, oat fibers, or combinations thereof.
In an embodiment of the invention, the water-insoluble fiber is selected from wheat fibers, oat fibers, or combinations thereof.
In an embodiment of the invention, the water-insoluble fiber is powdered cellulose.
Non-limiting examples of usable water-insoluble fibers include Vitacel WF 600, Vitacel HF 600, Vitacel P95, Vitacel WF 200, Vitacel LOO, Vitacel Erbsenfaser EF
150, Vitacel bamboo fiberbaf 90, Vitacel HF 600, Vitacel Cellulose L700G, Vitacel PF200, Vitacel potatofiber KF200, Vitacel bamboo fiberhaf BAF40, Vitacel Haferfaser/oat fiber HF-401-30 US.

PCT/D1(2021/050334 Non-limiting examples of usable powdered cellulose include Vitacel L 00, Vitacel Cellulose L700G, Vitacel LC1000, Vitacel L600-20, Vitacel L600 etc.
In an embodiment, the powdered cellulose is chemically unmodified. Thus, powdered cellulose may be chemically unmodified cellulose fibers, which do not include e.g.
microcrystalline cellulose (MCC).
In an advantageous embodiment of the invention, the water-insoluble fiber has a water binding capacity of at least 200%, such as at least 300%, such as at least 400%.
An advantage of the above embodiment may be that the high water-binding capacity enables pouch compositions having a high water-content.
Furthermore, the pouches having a high water-content where found to have a desirable texture and mouthfeel may while still being able to store manufactured pouches together in abutment e.g. in cans etc. without sticking too much together to result in ruptures of the pouches when being removed.
Also, water-insoluble fibers having a high water-binding capacity may reduce any nicotine exchange induced by the divalent cations happening prior to the pouch being used.
Hence, pouches comprising water-insoluble fibers having a high water-binding capacity could advantageously have a decreased relative standard deviation (RSD) on the nicotine content.
In an advantageous embodiment of the invention, the content of nicotine between a series of at least 10 oral pouches comprising said pouch composition holds a relative standard deviation (RSD) below 10%, preferably below 8%, more preferably at most 6%, even more preferably at most 4%, most preferably at most 2%.

PCT/D1(2021/050334 In an embodiment of the invention, the content of the nicotine between a series of at least 10 oral pouches comprising said pouch composition holds a relative standard deviation (RSD) of 0.1 - 10%, preferably 0.1 - 8%, more preferably 0.1 - 6%, even more preferably 0.1 - 4%, and most preferably 0.1 ¨ 2%.
In an embodiment of the invention, the water-insoluble fiber has a water binding capacity of 300 to 1500%, such as 400 to 1300%.
In an embodiment of the invention, the water-insoluble fiber has a water binding capacity of 200% to 1500%, such as 300 to 1300%, such as 200 to 800%, such as to 800%, such as 400 to 600%.
In an embodiment of the invention, the water-insoluble fiber has a water binding capacity of 200 to 1500%, such as 300 to 1300%, such as 300 to 900%, such as 300 to 700%, such as 400 to 700%.
In an embodiment of the invention, the water-insoluble fiber has a water binding capacity of 200 to 1500%, such as 400 to 1500%, such as 500 to 1500%, such as to 1200%, such as 500 to 1000%.
In an embodiment of the invention, the water-insoluble fiber has a swelling capacity of at least 5.0 mL/g, such as 5.0 ¨ 20 mL/g.
An advantage of the above embodiment is that the amount of water-insoluble fiber can be reduced without compromising the mouthfeel during use. If an amount of water-insoluble fiber is substituted for a water-soluble component, the swelling of the water-insoluble fiber will during use counteract the dissolution of the water-soluble component, thereby the user will not experience any decrease in pouch content during use.

PCT/D1(2021/050334 In an embodiment of the invention, the water-insoluble fibers are selected from pea fibers, powdered cellulose, and combinations thereof, and wherein the pouch composition comprises flavor in an amount of no more than 10% by weight of the pouch composition.
In an embodiment of the invention, the pouch composition comprises water-insoluble fibers selected from pea fibers and powdered cellulose, or a combination thereof, and flavor in an amount of 0.01 - 10% by weight of the pouch composition.
In an advantageous embodiment of the invention, the water-insoluble fiber has a density of 50 to 500 gram per Liter, such as 100 to 400 gram per Liter, such as 200 to 300 gram per Liter.
The use of water-insoluble fiber having a relatively low bulk density, will provide not only a good mouthfeel, but also an effective release from the pouch, due to the fact that a relatively low bulk density promotes effective salivation, thereby dissolution and release of water-soluble ingredients of the composition.
In an advantageous embodiment of the invention, the pouch composition comprises a pH regulating agent.
In an advantageous embodiment of the invention, the pouch composition comprises pH regulating agent in an amount between 0.01 and 15% by weight of the pouch composition, such as between 0.5 and 10% by weight of the pouch composition, such as between 1 and 10% by weight of the pouch composition, such as between 5 and 10% by weight of the pouch composition.
Obtaining a relatively fast release rate of nicotine and an effective uptake/absorption may be desirable as this ensures a fast effect for the user, i.e. craving relief.
Furthermore, the combination of having an effective release and an effective absorption advantageously enables a relative high exploitation of the nicotine dose PCT/D1(2021/050334 within the pouch. Having a relative high exploitation of the nicotine dose within the pouch may further provide a reduction of necessary nicotine dose of the pouch, without compromising the resulting effect. A lower nicotine dose may in tern result in a reduction in production cost, as nicotine may be relatively expensive, but may also 5 assist users who want to lower their intake of nicotine.
In an advantageous embodiment of the invention, the pH regulating agent is a basic pH regulating agent, such as a basic buffering agent.
10 In an advantageous embodiment of the invention, the p1-1 regulating agent is a buffering agent, such as a basic buffering agent.
In an embodiment of the invention, the pH regulating agent is water-soluble.
15 In an embodiment of the invention, the pH regulating agent is having water-solubility of at least 5 gram per 100 mL of water measured at 25 degrees Celsius, atmospheric pressure and pH 7Ø
In an embodiment of the invention, the pouch composition is adapted to give a pH of 20 at least 8.0, such as a pH of at least 9.0, when 2.0 gram of pouch composition is added to 20 mL of 0.02 M potassium di hydrogen phosphate-buffer (pH adjusted to 7.4).
An advantage of the above embodiment may be that a relatively effective uptake of nicotine is facilitated due to the high pH value obtained.
A further advantage of the above embodiment may be that the need for preservative may be decreased or even eliminated and that low amounts of such preservatives may be used if not absent.

PCT/D1(2021/050334 Also, the high pH value obtained may advantageously provide for a tingling sensation in the mouth which may be perceived as a desirable mouthfeel, e.g. due to resemblance with tobacco-based pouch products.
In an embodiment of the invention, the pH regulating agent is selected from the group consisting of Acetic acid, Adipic acid, Citric acid, Fumaric acid, Glucono-6-lactone, Gluconic acid, Lactic acid, Malic acid, Maleic acid, Tartaric acid, Succinic acid, Propionic acid, Ascorbic acid, Phosphoric acid, Sodium orthophosphate, Potassium orthophosphate, Calcium orthophosphate, Sodium diphosphate, Potassium diphosphate, Calcium di phosphate, Pentasodium triphosphate, Pentapotassium triphosphate, Sodium polyphosphate, Potassium polyphosphate, Carbonic acid, Sodium carbonate, Sodium bicarbonate, Potasium carbonate, Calcium carbonate, Magnesium carbonate, Magnesium oxide, or any combination thereof In an embodiment of the invention, the pH regulating agent is selected from the group consisting of Acetic acid, Adipic acid, Citric acid, Fumaric acid, Glucono-6-lactone, Gluconic acid, Lactic acid, Malic acid, Maleic acid, Tartaric acid, Succinic acid, Propionic acid, Ascorbic acid, Phosphoric acid, Sodium orthophosphate, Potassium orthophosphate, Sodium diphosphate, Potassium diphosphate, Pentasodium triphosphate, Pentapotassium triphosphate, Sodium polyphosphate, Potassium polyphosphate, Carbonic acid, Sodium carbonate, Sodium bicarbonate, Potassium carbonate, Magnesium carbonate, Magnesium oxide, or any combination thereof In an advantageous embodiment of the invention, the pH regulating agent is selected from the group consisting Sodium carbonate, Sodium bicarbonate, Potassium carbonate, and Magnesium carbonate; Potassium bicarbonate; trometamol;
phosphate buffer, amino acids, or any combination thereof.
In an embodiment, the pouch composition comprises inorganic divalent cations, which may be provided as a water soluble salt, and in addition thereto a pH
regulating agent selected from the group consisting Sodium carbonate, Sodium bicarbonate, Potassium PCT/D1(2021/050334 carbonate, and Magnesium carbonate; Potassium bicarbonate; trometamol;
phosphate buffer; amino acids, or any combination thereof In an embodiment, the pouch composition comprises inorganic divalent cations, which may be provided as a water soluble salt, and in addition thereto a pH
regulating agent selected from the group consisting Sodium carbonate, Sodium bicarbonate, Potassium carbonate, and Magnesium carbonate; Potassium bicarbonate; trometamol;
phosphate buffer; or any combination thereof In an embodiment, the pouch composition comprises inorganic divalent cations, which may be provided as a water soluble salt, and in addition thereto a pH
regulating agent selected from the group consisting Sodium carbonate, Sodium bicarbonate, Potassium carbonate, and Magnesium carbonate; Potassium bicarbonate; trometamol; or any combination thereof In the present context the term "trometamol" refers to (tris(hydroxymethyl)aminomethane), also sometimes referred to as tris buffer.
In the present context, the term "phosphate buffer" refers to alkali metal and alkaline earth metal phosphate salts, such as Sodium orthophosphate, Potassium orthoph osph ate, Calcium orthophosph ate, Sodium di phosphate, Potassium diphosphate, Calcium diphosphate, Pentasodium triphosphate, Pentapotassium triphosphate, Sodium polyphosphate, Potassium polyphosphate.
In an advantageous embodiment of the invention, the pH adjusting agent is selected from the group consisting of trometamol, amino acids and phosphate buffer, or any combination thereof In an advantageous embodiment of the invention, the pH adjusting agent is selected from the group consisting of trometamol and phosphate buffer, or any combination thereof PCT/D1(2021/050334 Trometamol and phosphate buffers have a desirable relative neutral taste, hence the use of these pH regulating agents may not compromise the taste and mouthfeel of the pouch composition.
In an advantageous embodiment of the invention, the pH adjusting agent is selected from the group consisting of trometamol.
In an embodiment of the invention, the pH adjusting agent is trometamol.
In an embodiment of the invention, the p1-1 adjusting agent comprises trometamol In an embodiment of the invention, the pH adjusting agent is amino acid.
In an embodiment of the invention, the pH adjusting agent comprises an amino acid.
In an embodiment of the invention, the pH adjusting agent is phosphate buffer.
In an embodiment of the invention, the pH adjusting agent comprises phosphate buffer.
In an embodiment of the invention, the pH adjusting agent is phosphate buffer selected from the group consisting of Sodium orthophosphate, Potassium orthophosphate, Calcium orthophosphate, Sodium diphosphate, Potassium diphosphate, Calcium diphosphate, Pentasodium triphosphate, Pentapotassium triphosphate, Sodium polyphosphate, Potassium polyphosphate, and combinations thereof In an embodiment, the pH regulating agent is an alkali metal phosphate buffer.
In an embodiment, the phosphate buffer is an alkali metal phosphate buffer.
In an embodiment, the phosphate buffer is an alkali metal phosphate buffer selected from the group consisting of Sodium orthophosphate, Potassium orthophosphate, PCT/D1(2021/050334 Sodium diphosphate, Potassium diphosphate, Pentasodium triphosphate, Pentapotassium triphosphate, Sodium polyphosphate, Potassium polyphosphate, and combinations thereof In an embodiment, the phosphate buffer is provided as a water-soluble composition.
In an embodiment of the invention, the pH adjusting agent does not comprise carbonate and/or bicarbonate.
In an embodiment of the invention, the pH adjusting agent is a non-carbonate and/or non-bicarbonate buffers, or combinations thereof In an embodiment of the invention, the pouch composition is free of carbonates.
In an embodiment of the invention, the pouch composition comprises humectant.
In an embodiment, the humectant is selected from the list of glycerol, propylene glycol, alginate, pectin, modified starch, hydroxypropyl cellulose, triacetin, polyethylene glycol (PEG), xanthan gum, and combinations thereof.
In an embodiment, the humectant is or comprises humectant in an amount of 0.5 to 10%, such as 0.5 to 5% by weight of the pouch composition, such as 1-3% by weight of the pouch composition.
In an embodiment, the humectant is or comprises alginate, such as sodium alginate, e.g. in an amount of 0.5 to 10%, such as 0.5 to 5% by weight of the pouch composition, such as 1-3% by weight of the pouch composition.
In an embodiment of the invention, the pouch composition is free of alginate.

PCT/D1(2021/050334 In an embodiment of the invention the pouch composition is free of humectants consisting of alginate, pectin and xanthan gum.
In an embodiment of the invention the pouch composition is free of humectants 5 selected from the list of glycerol, propylene glycol, alginate, pectin, modified starch, hydroxypropyl cellulose, triacetin, polyethylene glycol (PEG), xanthan gum, and combinations thereof In an embodiment of the invention the pouch composition is free of humectants.
In an advantageous embodiment of the invention, the pouch composition is adapted to release at least 30% nicotine within 10 minutes when exposed to in vitro conditions described in example 7A.
In an advantageous embodiment of the invention, the pouch composition is adapted to release at least 25% more nicotine within 5 minutes compared to a corresponding pouch composition without divalent cations when exposed to the in vitro conditions described in example 7A.
In an advantageous embodiment of the invention, the pouch composition comprises sodium chloride in an amount of 0.0-3.0% by weight of the pouch compositions, such as 0.05 ¨ 1.0 A by weight of the pouch composition, such as 0.1 ¨ 1.0% by weight of the pouch composition.
Sodium chloride may advantageously be added in small amounts, i.e. 0.0-3.0% by weight as a flavor enhancer. Adding higher amounts of sodium chloride could induce an undesirable taste or mouthfeel.
In an advantageous embodiment of the invention, the pouch composition further comprises a preservative.

PCT/D1(2021/050334 The preservative may help to preserve the pouch composition against undesirable microbiological growths.
In an advantageous embodiment of the invention, the pouch composition further comprises a preservative in an amount of 0.05 to 0.5% by weight of the pouch composition, such as 0.1 to 0.2% by weight of the pouch composition.
Non-limiting examples of usable preservatives within the scope of the invention includes sorbic acid (E200) and salts thereof (e.g. sodium sorbate (E201), potassium sorbate (E202), calcium sorbate (E203)), benzoic acid (E210) and salts thereof (e.g.
sodium benzoate (E211), potassium benzoate (E212), calcium benzoate (E213)).
In an advantageous embodiment of the invention, the pouch composition comprises less than 0.1% by weight of preservatives, such as less than 0.05% by weight of preservatives.
Thus, the pouch composition may comprise preservatives in an amount of 0 to 0.1 %
by weight of preservatives, such as in an amount of 0 to 0.05% by weight of preservatives. This includes zero content of preservatives, i.e. that the pouch composition is free of preservatives. The low amount or even absence of preservative may be realized by obtaining a relatively alkaline environment, particularly by the use of free-base nicotine.
In an advantageous embodiment of the invention, the pouch composition is free of preservatives.
In an advantageous embodiment of the invention, the pouch composition is a non-tobacco pouch composition.

PCT/D1(2021/050334 In an advantageous embodiment of the invention, the pouch composition comprises less than 2.00/0 by weight of tobacco, such as less than 1.0% by weight of tobacco, such as less than 0.5% by weight of tobacco, such as 0.0% by weight of tobacco.
In an advantageous embodiment of the invention, the pouch composition comprises a non-tobacco fiber.
In an advantageous embodiment of the invention, the pouch composition is a powdered composition.
The invention further relates to an oral pouched nicotine product comprising a saliva-permeable pouch and the pouch composition of according to the invention or any of its embodiments enclosed in said pouch.
In an advantageous embodiment of the invention, the pouched nicotine product comprises nicotine in an amount of 0.5 to 20 mg, such as 1.0 to 20 mg, such as 5.0 to 15 mg.
In an advantageous embodiment of the invention, the pouched nicotine product comprises nicotine-ion exchange combination in an amount of 1 to 100 mg per pouch.
In an embodiment of the invention, the pouched nicotine product comprises nicotine-ion exchange combination in an amount of 1 to 100 mg per pouch, such as 10 to mg per pouch, such as 10 to 80 mg per pouch, such as 20 to 80 mg per pouch, such as 30 to 80 mg per pouch, such as 40 to 80 mg per pouch, such as 50 to 80 mg per pouch.
In an embodiment of the invention, the pouched nicotine product comprises nicotine-ion exchange combination in an amount of 1 to 100 mg per pouch, such as 10 to mg per pouch, such as 10 to 60 mg per pouch, such as 20 to 60 mg per pouch, such as 20 to 50 mg per pouch.

PCT/D1(2021/050334 In an embodiment of the invention, the divalent cations are provided as a salt having a water-solubility of 5 - 500 grams per 100 mL of water measured at 25 degrees Celsius, atmospheric pressure and pH 7.0, such as 5 - 350 grams per 100 mL of water measured at 25 degrees Celsius, atmospheric pressure and pH 7Ø
In an embodiment of the invention, the inorganic divalent cations are provided as a salt in an amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0%
by weight of the composition, and the inorganic divalent cations are provided as an inorganic salt comprising inorganic anions selected from the group consisting of chloride, bromide, hydrogen carbonate, sulfate, and any combination thereof In an embodiment of the invention, the inorganic divalent cations are provided as a salt in an amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0%
by weight of the composition, and the divalent cations are provided as a water-soluble salt having a water-solubility of at least 5 gram per 100 mL of water measured at 25 degrees Celsius, atmospheric pressure and pH 7Ø
In an embodiment of the invention, the inorganic divalent cations are provided as an inorganic salt in an amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0% by weight of the composition, and the water-soluble salt has a water-solubility of at least 5 gram per 100 mL of water measured at 25 degrees Celsius, atmospheric pressure and pH 7Ø
In an embodiment of the invention, the inorganic divalent cations are provided as a salt in an amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0%
by weight of the composition and the pouch composition comprises nicotine in an PCT/D1(2021/050334 amount of at least 0.1% by weight, such as least 0.2% by weight of the pouch composition.
In an embodiment of the invention, the inorganic divalent cations are provided as a salt in an amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0%
by weight of the composition, the pouch composition comprises nicotine in an amount of at least 0.1% by weight, such as least 0.2% by weight of the pouch composition, and the solid oral nicotine formulation comprises inorganic divalent cations in a molar ratio of at most 5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 3.75 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 2.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
In an embodiment of the invention, the inorganic divalent cations are provided as a salt in an amount of between 0.1 and 150% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0%
by weight of the composition, the pouch composition comprises nicotine in an amount of at least 0.1% by weight, such as least 0.2% by weight of the pouch composition, and the pouch composition comprises inorganic divalent cations in a molar ratio of at most 6.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 6.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 3.75 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 2.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
In an embodiment of the invention, the inorganic divalent cations are provided as a salt in an amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0%

PCT/D1(2021/050334 by weight of the composition, and the pouch composition comprises nicotine-ion exchange combination in an amount of 0.1 to 20% by weight of the pouch composition.
In an embodiment of the invention, the inorganic divalent cations are provided as a 5 salt in an amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0%
by weight of the composition, and the pouch composition comprises nicotine-ion exchange combination in an amount of 0.1 to 20% by weight of the pouch composition, and the solid oral nicotine formulation comprises inorganic divalent cations in a molar 10 ratio of at most 5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 3.75 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 2.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
15 In an embodiment of the invention, the inorganic divalent cations are provided as a salt in an amount of between 0.1 and 150% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0%
by weight of the composition, and the pouch composition comprises nicotine-ion exchange combination in an amount of 0.1 to 20% by weight of the pouch composition, 20 and the pouch composition comprises inorganic divalent cations in a molar ratio of at most 6.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 6.0 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 3.75 relative to the 25 amount of nicotine in the nicotine-ion exchange resin combination, such as at most 2.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
In an embodiment of the invention, the nicotine-ion exchange resin combination comprises nicotine in an amount of between 5 and 50% by weight and ion-exchange 30 resin in an amount between 10 and 95% by weight, and the ion exchange resin is polacrilex resin.

PCT/D1(2021/050334 In an embodiment of the invention, the pouch composition comprises nicotine-ion exchange combination in an amount of 0.1 to 20% by weight of the pouch composition, and the nicotine-ion exchange resin combination comprises nicotine in an amount of between 5 and 50% by weight and ion-exchange resin in an amount between 10 and 95% by weight, and the ion exchange resin is polacrilex resin.
In an embodiment of the invention, the inorganic divalent cations are provided as a salt in an amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0%
by weight of the composition, and the pouch composition comprises nicotine-ion exchange combination in an amount of 0.1 to 20% by weight of the pouch composition, and the pouch composition comprises water in an amount of 15-65% by weight of the composition, such as 15-60% by weight of the composition, such as 15-500/o by weight of the composition, such as 20-50% by weight of the composition, such as 20-40% by weight of the composition In an embodiment of the invention, the at least one sugar alcohol is selected from xylitol, maltitol, mannitol, erythritol, isomalt, sorbitol, lactitol, and mixtures thereof, and the pouch composition comprises sugar alcohol in an amount of 1 to 80% by weight of the composition, such as 2 to 70% by weight of the composition, such as 5 to 60% by weight of the composition, such as 10 to 50% by weight of the composition, such as 15 to 50% by weight of the composition.
In an embodiment of the invention, the inorganic divalent cations are provided as a salt in an amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0%
by weight of the composition, and the pouch composition comprises nicotine-ion exchange combination in an amount of 0.1 to 20% by weight of the pouch composition, and the pouch composition comprises water in an amount of 15-65% by weight of the composition, such as 15-60% by weight of the composition, such as 15-50% by weight PCT/D1(2021/050334 of the composition, such as 20-50% by weight of the composition, such as 20-40% by weight of the composition, and the pouch composition comprises sugar alcohol in an amount of 1 to 80% by weight of the composition, such as 2 to 70% by weight of the composition, such as 5 to 600/o by weight of the composition, such as 10 to 50% by weight of the composition, such as 15 to 50% by weight of the composition.
In an embodiment of the invention, the pouch composition comprises sugar alcohol in an amount of 1 to 80% by weight of the composition, such as 2 to 70% by weight of the composition, such as 5 to 60% by weight of the composition, such as 10 to by weight of the composition, such as 15 to 50% by weight of the composition, and the pouch composition comprises said water-insoluble fiber in an amount between 5 and 50 % by weight of the pouch composition, such as 10-45% by weight of the pouch composition, such as 15-40% by weight of the pouch composition.
In an embodiment of the invention, the pouch composition comprises sugar alcohol in an amount of 1 to 80% by weight of the composition, such as 2 to 70% by weight of the composition, such as 5 to 60% by weight of the composition, such as 10 to 50%
by weight of the composition, such as 15 to 50% by weight of the composition, and the pouch composition comprises said water-insoluble fiber in an amount between 5 and 50 % by weight of the pouch composition, such as 10-45% by weight of the pouch composition, such as 15-40% by weight of the pouch composition, and the pouch composition comprises water in an amount of 15-65% by weight of the composition, such as 15-60% by weight of the composition, such as 15-50% by weight of the composition, such as 20-50% by weight of the composition, such as 20-40% by weight of the composition.
In an embodiment of the invention, the pouch composition comprises said water-insoluble fiber in an amount between 5 and 50 % by weight of the pouch composition, such as 10-45% by weight of the pouch composition, such as 15-40% by weight of the pouch composition, and the water-insoluble fiber is selected from wheat fibers, pea fibers, rice fiber, maize fibers, oat fibers, tomato fibers, barley fibers, rye fibers, sugar PCT/D1(2021/050334 beet fibers, buckwheat fibers, potato fibers, cellulose fibers, apple fibers, cocoa fibers, cellulose fibers, bran fibers, bamboo fibers, powdered cellulose, and combinations thereof In an embodiment of the invention, the inorganic divalent cations are provided as a salt in an amount of between 0.1 and 15.0% by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0%
by weight of the composition, and the pouch composition comprises nicotine-ion exchange combination in an amount of 0.1 to 20% by weight of the pouch composition, and the pouch composition comprises water in an amount of 15-65% by weight of the composition, such as 15-60% by weight of the composition, such as 15-500/0 by weight of the composition, such as 20-50% by weight of the composition, such as 20-40% by weight of the composition, and the pouch composition comprises sugar alcohol in an amount of 1 to 80% by weight of the composition, such as 2 to 70% by weight of the composition, such as 5 to 60% by weight of the composition, such as 10 to 50%
by weight of the composition, such as 15 to 50% by weight of the composition, and the pouch composition comprises said water-insoluble fiber in an amount between 5 and 50 % by weight of the pouch composition, such as 10-45% by weight of the pouch composition, such as 15-40% by weight of the pouch composition.
In an embodiment of the invention, the pouch composition comprises pH
regulating agent in an amount between 0.01 and 15% by weight of the pouch composition, such as between 0.5 and 10% by weight of the pouch composition, such as between 1 and 10% by weight of the pouch composition, such as between 5 and 10% by weight of the pouch composition, and the pH regulating agent is selected from the group consisting Sodium carbonate, Sodium bicarbonate, Potassium carbonate, and Magnesium carbonate; Potassium bicarbonate; trometamol; phosphate buffer, or any combination thereof.
In an embodiment of the invention, the pouch composition comprises pH
regulating agent in an amount between 0.01 and 15% by weight of the pouch composition, such PCT/D1(2021/050334 as between 0.5 and 10% by weight of the pouch composition, such as between 1 and 100/0 by weight of the pouch composition, such as between 5 and 10% by weight of the pouch composition, and the pH regulating agent is selected from the group consisting Sodium carbonate, Sodium bicarbonate, Potassium carbonate, and Magnesium carbonate; Potassium bicarbonate; trometamol; phosphate buffer, or any combination thereof, and the divalent cations are provided as a water-soluble salt haying a water-solubility of at least 5 gram per 100 mL of water measured at degrees Celsius, atmospheric pressure and pH 7Ø
In an embodiment of the invention, the pouch composition comprises pH
regulating agent in an amount between 0.01 and 15% by weight of the pouch composition, such as between 0.5 and 10% by weight of the pouch composition, such as between 1 and 10% by weight of the pouch composition, such as between 5 and 10% by weight of the pouch composition, and the pH regulating agent is selected from the group consisting Sodium carbonate, Sodium bicarbonate, Potassium carbonate, and Magnesium carbonate; Potassium bicarbonate; trometamol; phosphate buffer, or any combination thereof, and the inorganic divalent cations are provided as an inorganic salt comprising inorganic anions selected from the group consisting of chloride, bromide, hydrogen carbonate, sulfate, and any combination thereof.
The invention further relates to a pouch composition comprising a nicotine-ion exchange resin combination, and inorganic multivalent cations.
In an advantageous embodiment of the invention, said multivalent cations are selected from the group consisting of multivalent ions of calcium, magnesium, zinc, aluminum, barium, iron, manganese, copper, lead, cobalt, nickel, such as Ca2+, Mg2+, Zn2+, A13+, Ba2+, Fe2+, Fe3+, Fe4+, Mn2+, Mn4+, Cu4+, or any combinations thereof.

PCT/D1(2021/050334 In an embodiment of the invention, the multivalent cations are selected from the group consisting of Ca2+, Mg2+, Zn2+, Ba2+, Fe2+, Fe3+, Fe4+, Al3+, Mn2+, Mn4+, Cu4+, and any combination thereof 5 In an advantageous embodiment of the invention, the multivalent cations are selected from the group consisting of trivalent cations of aluminum, divalent cations of calcium, magnesium, iron, zinc, and any combination thereof In an advantageous embodiment of the invention, the multivalent cations are trivalent 10 cations.
In an embodiment the trivalent cation is aluminum.
In an embodiment of the invention, the multivalent cations comprise aluminum 15 chloride In an embodiment of the invention, the multivalent cations are selected from the group consisting of aluminum chloride, divalent cations of calcium, magnesium, iron, zinc, and any combination thereof In an advantageous embodiment of the invention, the multivalent cations are selected from the group consisting of divalent cations of calcium, magnesium, iron, zinc, and any combination thereof In an advantageous embodiment of the invention, the multivalent cations are selected from the group consisting of divalent cations of calcium, magnesium, and any combination thereof PCT/D1(2021/050334 DETAILED DESCRIPTION
As used herein the term "pouch composition" refers to the composition for use in an oral pouch, i.e. in pouches for oral use. Thus, pouch composition refers to the composition enclosed within the pouch. Also, the terms "pouch composition-, "nicotine pouch composition" and "solid oral nicotine formulation" are used interchangeably, when referring to the composition being enclosed within the pouch.
As used herein the term -nicotine" refers to nicotine used as a refined/isolated substance. Particularly, nicotine does not refer to tobacco materials having a content of nicotine. Thus, when referring to nicotine amounts also to be understood as the nicotine dose, the amounts refers to the amount of pure nicotine.
Nicotine also covers nicotine not obtained from tobacco, often referred to as synthetic nicotine.
As used herein, a "molar ratio" refers to the ratio of the molar content of the first component divided by the molar content of the second component.
The relative content between the first component and the second component may also be presented as equivalents of the first component relative to the second component.
Thus, a pouch comprising divalent cations in a molar ratio of 0.1 relative to the amount of nicotine in the nicotine-ion exchange resin combination, may also be presented as a pouch comprising 0.1 eq. of divalent cations relative to the amount of nicotine in the nicotine-ion exchange resin combination, i.e. a pouch comprising 0.1 eq. of divalent cations and 1 eq. of nicotine in the nicotine-ion exchange resin combination.
As used herein the term "free-base nicotine" refers to non-protonated form of nicotine, and therefore does not include nicotine salts or nicotine provided as a complex between nicotine and an ion exchange resin. Nevertheless, the free-base nicotine may be mixed with an amount of ion exchange resin or water-soluble compositions such as sugar alcohols or water-soluble fibers. While free-base nicotine includes both free-base nicotine extracted from tobacco as well as synthetically manufactured free-base PCT/D1(2021/050334 nicotine, the free-base nicotine is not provided in the form of tobacco or powdered tobacco. Typically, free-base nicotine is provided as a liquid.
As used herein the term "pouch" is intended to mean a container typically formed by a web of a fibrous material enclosing a cavity. The pouch is pouch designed for administration of an active ingredient in the oral cavity, and thus it is adapted for oral use, it is non-toxic and not water-soluble. The fibrous material may e.g. form a woven or non-woven web or fabric. The pouch may for example be sealed by bonding two corresponding pieces of web or fabric to each other along their edges to form a cavity for the nicotine and the non-water-soluble composition. In order to release the nicotine, the pouch is made water-permeable so as to allow saliva from the oral cavity to penetrate the pouch and enter the cavity, where the saliva can come into contact with the nicotine, whereby the nicotine are released from the oral pouch.
As used herein, the term "nicotine-ion exchange resin combination" refer to a combination comprising nicotine complexed with ion exchange resin and/or free-base nicotine mixed with ion exchange resin.
As used herein, the term "nicotine complexed with ion-exchange resin" refers to nicotine bound to an ion exchange resin.
In the present context, the term "free-base nicotine mixed with ion exchange resin"
refers to a mixture comprising free-base nicotine and ion exchange resin. It is noted that even if some embodiments comprise a combination of nicotine complexed with ion exchange resin and nicotine in its free-base form mixed with ion exchange resin, the term "free-base nicotine mixed with ion exchange resin" requires the presence of nicotine in its free-base form. In some embodiments, the mixture is an aqueous mixture. Free-base nicotine and water is mixed with ion-exchange resin, whereby a mixture comprising both free-base nicotine and ion exchange resin is obtained.
Free-base nicotine mixed with ion exchange resin is referred to as "premix" in the examples.

PCT/D1(2021/050334 As used herein the term "powder composition" refers to composition in the form of powder, i.e. as a particulate material having a relatively small particle size, for example between 1 and 1200 micrometer. Particularly, by powder composition is not meant a powdered tobacco.
As used herein the term "humectant" is understood as a moistening agent used to keep pouches moist, i.e. a humectant is added to the pouch composition with the purpose of keeping the pouch moist. Hence, the term humectant does not refer to substances added for other purposes, hereunder also hygroscopic substances added for other purposes, such as sugar alcohols, water-insoluble fibers and glycerol associated with ion-exchange resin in nicotine-ion exchange resin combinations, such as nicotine polacrilex. Examples of humectants include alginate, propylene glycol, hydroxypropyl cellulose, and glycerol. It is noted that when glycerol is included as a humectant, the glycerol is added as free glycerol and therefore liquid at room temperature.
Further examples of humectants include triacetin, modified starch, pectin, xanthan gum, etc.
The term humectant does not refer to sugar alcohols comprising 4 or more carbons.
Also, the term humectant does not refer to fibers, such as water-insoluble fiber, such as wheat fibers, pea fibers, rice fiber, maize fibers, oat fibers, tomato fibers, barley fibers, rye fibers, sugar beet fibers, buckwheat fibers, potato fibers, cellulose fibers, apple fibers, cocoa fibers, cellulose fibers, bran fibers, bamboo fibers, powdered cellulose, and combinations thereof. Also, the term humectant does not include e.g.
NaCl.
As used herein the term "water-soluble" refers to a relatively high water-solubility, for example a water-solubility of more than 5 gram of water-soluble composition or substance per 100 mL of water measured at 25 degrees Celsius, atmospheric pressure and pH of 7Ø When referring to a "soluble" composition or substance, water-soluble is meant, unless otherwise stated.
As used herein the term "water-insoluble" refers to relatively low water-solubility, for example a water-solubility of less than 0.1 gram of composition or substance per 100 PCT/D1(2021/050334 mL of water measured at 25 degrees Celsius, atmospheric pressure and pH of 7Ø
When referring to "insoluble", water-insoluble is meant unless otherwise stated.
Therefore, compositions or substances having a water-solubility of between 0.1 and 5 gram per of composition or substance per 100 mL of water measured at 25 degrees Celsius, atmospheric pressure and pH of 7.0 are considered neither water-soluble nor water-insoluble, but having an intermediate water-solubility.
The pouches of the invention provide a nicotine release into the oral cavity.
A release profile of nicotine may be obtained which both comprises a fast release period and a sustained release period.
As used herein the term "fast release" or "fast release period" may refer to the initial 2 minutes of the nicotine release profile, whereas the term "sustained release period refers" to the subsequent period of the release profile until end of experiment or end of use.
As used herein the term "fast release rate" refers to the released nicotine per minute within the initial 2 minutes.
As used herein the term -effective release" refers to the total release of nicotine over the release period of the experiment or the use period.
As used herein, the term "dissolve" is the process where a solid substance enters a solvent (such as oral saliva or water within the pouch) to yield a solution.
Typically, the pouches comprise openings, where the characteristic opening dimension is adapted to a characteristic dimension of the matrix composition so as to retain the matrix composition inside the pouch before use and/or to retain a part of the matrix composition, such as an water-insoluble composition, inside the pouch during use.

PCT/D1(2021/050334 In order to obtain a pouch having suitable opening dimensions in view of the matrix composition to be used, the material for the pouch may be selected accordingly, e.g.
comprising e.g. woven and/or non-woven fabric.
5 In other words, according to the various embodiments, the pouch forms a membrane allowing passage of saliva and prevents or inhibits passage of said matrix composition.
The membrane of the pouch may be of any suitable material e.g. woven or non-woven fabric (e.g. cotton, fleece etc.), heat sealable non-woven cellulose or other polymeric materials such as a synthetic, semi-synthetic or natural polymeric material.
An 10 example of suitable pouch material is paper made of pulp and a small amount of wet strength agent. A material suitable for use must provide a semi-permeable membrane layer to prevent the powder or composition from leaving the bag or pouch during use.
Suitable materials are also those that do not have a significant impact on the release of nicotine from the pouch.
The pouch composition is filled into pouches and is maintained in the pouch by a sealing. An ideal pouch is chemically and physically stable, it is pharmaceutically acceptable, it is insoluble in water, it is easy to fill with powder and seal, and it provides a semi-permeable membrane layer which prevent the powder from leaving the bag, but permit saliva and therein dissolved or sufficiently small suspended components from the pouch composition in the pouch, such as nicotine, to pass through said pouch.
The pouch may be placed in the oral cavity by the user. Saliva then enters into the pouch, and the nicotine and other components, which are soluble in saliva, start to dissolve and are transported with the saliva out of the pouch into the oral cavity, where the nicotine may be absorbed.
According to an embodiment of the invention, the pouch composition may further comprise one or more additives.

PCT/D1(2021/050334 In an embodiment of the invention, said additives are selected from the group consisting of bile salts, cetomacrogols, chelating agents, citrates, cyclodextrins, detergents, enamine derivatives, fatty acids, labrasol, lecithins, phospholipids, syntetic and natural surfactants, nonionic surfactants, cell envelope disordering compounds, solvents, steroidal detergents, chelators, solubilization agents, charge modifying agents, pH regulating agents, degradative enzyme inhibitors, mucolytic or mucus clearing agents, membrane penetration-enhancing agents, modulatory agents of epithelial junction physiology, vasodilator agents, selective transport-enhancing agents, or any combination thereof pH regulating agents include buffers.
In an embodiment of the invention, said additives are selected from the group consisting of cetylpyridinium chloride (CPC), benzalkonium chloride, sodium lauryl sulfate, polysorbate 80, Polysorbate 20, cetyltrimethylammonium bromide, laureth 9, sodium salicylate, sodium EDTA, EDTA, aprotinin, sodium taurocholate, saponins, bile salt derivatives, fatty acids, sucrose esters, azone emulsion, dextran sulphate, linoleic acid, labrafil, transcutol, urea, azone, nonionic surfactants, sulfoxides, sauric acid/PG, POE 23 lauryl ether, methoxysalicylate, dextran sulfate, methanol, ethanol, sodium cholate, Sodium taurocholate, Lysophosphatidyl choline, Alkylglycosides, polysorbates, Sorbitan esters, Poloxamer block copolymers, PEG-35 castor oil, PEG-hydrogenated castor oil, Caprocaproyl macrogo1-8 glycerides, PEG-8 caprylic/capric, glycerides, Dioctyl sulfosuccinate, Polyethylene lauryl ether, Ethoxydiglycol, Propylene glycol, mono-di-caprylate, Glycerol monocaprylate, Glyceryl fatty acids (C8-C 18) ethoxylated Oleic acid, Linoleic acid, Glyceryl caprylate/caprate, Glyceryl monooleate, Glyceryl monolaurate, Capryliccapric triglycerides, Ethoxylated nonylphenols, PEG-(8-50) stearates, Olive oil PEG-6, esters, Triolein PEG-6 esters, Lecithin, d-alpha tocopherol polyethylene glycol 1,000 succinate, Citric acid, Sodium citrate, BRIJ, Sodium laurate, 5-methoxysalicylic acid, Bile salts, Acetyl salicylate, ZOT, Docosahexaenoic acid, Alkylglycosides, Sodium glycocholate (GC-Na), Sodium taurocholate (TC-Na), EDTA, Choline salicylate, Sodium caprate (Cap-Na), N-lauryl-beta-D-maltopyranoside (LM), Diethyl maleate, Labrasol, Sodium salicylate, Mentol, Alkali metal alkyl sulphate, Sodium lauryl sulphate, Glycerin, Bile PCT/D1(2021/050334 acid, Lecithin, phosphatidylcholine, phosphatidylserine, sphingomy elin, phophatidylethanolamine, cephalin, lysolecithin, Hyaluronic acid: alkalimetal salts, sodium, alkaline earth and aluminum, Octylphenoxypolyethoxyethanol, Glycolic acid, Lactic acid, Chamomile extract, Cucumber extract, Borage oil, Evening primrose oil, Polyglycerin, Lysine, Polylysine, Triolein, Monoolein, Monooleates, Monolaurates, Polydocanol alkyl ethers, Chenodeoxycholate, Deoxycholate, Glycocholic acid, Taurocholic acid, Glycodeoxycholic acid, Taurodeoxycholic acid, Sodium glycocholate, Phosphatidylcholine, Phosphatidylserine, Sphi ngomy el in, Phosphatidylethanolamine, Cephalin, Lysolecithin, Alkali metal hyaluronates, Chitosan, Poly-L-arginine, Alkyl glucoside, Saccharide alkyl ester, Fusidic acid derivatives, Sodium taurdihydrofusidate (STDHF), L-a-phosphatidylcholine Didecanoyl (DDPC), Nitroglycerine, nitropruside, N005 [3-(2-hydroxy-1-(methyl-ethyl)-2-nitrosohydrazino)-1- propanamine], NOC12 [iV-ethy1-2-(1-ethyl-hydroxy-nitrosohydrazino)-ethanamine, SNAP [S-nitroso-N-acetyl-DL-penicillamine, NORI, NOR4, deacylmethyl sulfoxide, azone, salicylamide, glycery1-1,3-diacetoacetate, 1,2-isopropylideneglycerine-3-acetoacetate), Amino acids, Amino acid salts, monoaminocarboxlic acids, Glycine, alanine, phenylalanine, proline, hydroxyproline, hydroxyamino acids, serine, acidic amino acids, aspartic acid, Glutamic acid, Basic amino acids, Lysine, N-acetylamino acids, N-acetylalanine, N-acetylphenylalanine, TM-acetylserine, N-acetylglycine, N-acetyllysine, N-acetylglutamic acid, N-acetylproline, N-acetylhydroxyproline , lactic acid, malic acid and citric acid and alkali metal salts thereof, pyrrolidonecarboxylic acids, alkylpyrrolidonecarboxylic acid esters, N-alkylpyrrolidones, proline acyl esters, sodium lauryl phosphate, sodium lauryl sulphate, sodium oleyl phosphate, sodium myristyl sulphate, polyoxyethylene alkyl ethers, polyoxyethylene alkyl esters, and caproic acid, alkylsaccharide, fusidic acid, polyethylene glycol, cetyl alcohol, polyvinylpyrolidone, Polyvinyl alcohol, Lanolin alcohol, Sorbitan monooleate, Ethylene glycol tetraacetic acid, Bile acid conjugate with taurine, Cholanic acid and salts, Cyclodextran, Cyclodextrin, Cy clodextrin (beta), Hy droxypropy1-13-cy clodetran, Sulfobutylether-I3-cy clod extran, Methyl-13-cyclodextrin, Chitosan glutamate, Chitosan acetate, Chitosan hydrochloride, Chitosan hydrolactate, 1-0-alkyl-2-hydroxy- sn-gly c ero-3 -phosphocholine, 3 -0-alkyl-PCT/D1(2021/050334 2-acetoyl-sn-glycero-1-phosphocholine, 1-0-alkyl-2-0-acetyl- sn-glycero-3-phospho(N,N,N-trimethyl)hexanolamine, Propylene glycol, Tetradecylmaltoside (TDM), Sucrose dedecanoate.
As used herein, the term "pH regulating agent- refers to agents, which active adjust and regulates the pH value of the solution to which they have been added or are to be added. Thus, pH regulating agents may be acids and bases, including acidic buffering agents and alkaline buffering agents. On the other hand, pH
regulating agents does not including substances and compositions that can only affect the pH by dilution. Furthermore, p1-1 regulating agents does not include e.g. flavoring, fillers, etc.
In an embodiment of the invention, said pH-regulating agents are selected from the group consisting of Acetic acid, Adipic acid, Citric acid, Fumaric acid, Glucono-6-lactone, Gluconic acid, Lactic acid, Malic acid, Maleic acid, Tartaric acid, Succinic acid, Propionic acid, Ascorbic acid, Phosphoric acid, Sodium orthophosphate, Potassium orthophosphate, Calcium orthophosphate, Sodium diphosphate, Potassium diphosphate, Calcium diphosphate, Pentasodium triphosphate, Pentapotassium triphosphate, Sodium polyphosphate, Potassium polyphosphate, Carbonic acid, Sodium carbonate, Sodium bicarbonate, Potasium carbonate, Calcium carbonate, Magnesium carbonate, Magnesium oxide, trometamol, phosphate buffers, amino acids, or any combination thereof.
According to various embodiments of the invention, one or more sugar alcohols may be included in the pouch as part of the pouch composition, e.g. as a carrier or part thereof, or as a sweetener. Suitable sugar alcohols include sugar alcohols selected from the group of sorbitol, erythritol, xylitol, lactitol, maltitol, mannitol, hydrogenated starch hydrolyzates, isomalt, or any combination thereof In an embodiment of the invention the pouch composition comprises high intensity sweetener.

PCT/D1(2021/050334 Preferred high intensity sweeteners include, but are not limited to sucralose, aspartame, salts of acesulfame, such as acesulfame potassium, alitame, saccharin and its salts, cyclamic acid and its salts, glycyrrhizin, dihydrochalcones, thaumatin, monellin, stevioside and the like, alone or in combination.
In an embodiment of the invention, the pouch composition comprises bulk sweeteners including sugar and/or sugarless components.
In an embodiment of the invention, the pouch composition comprises bulk sweetener in the amount of 1.0 to about 80% by weight of the pouch composition, more typically constitute 5 to about 70% by weight of the pouch composition, and more commonly 10 to 60% by weight of the pouch composition or 10-50% by weight of the pouch composition. Bulk sweeteners may function both as a sweetener and also as a humectant. In some embodiments, inclusion of certain ingredients may limit the about amounts of bulk sweetener further.
The sweeteners may often support the flavor profile of the pouch composition.
Sugar sweeteners generally include, but are not limited to saccharide-containing components commonly known in the art of pouches, such as sucrose, dextrose, maltose, saccharose, lactose, sorbose, dextrin, trehalose, D-tagatose, dried invert sugar, fructose, levulose, galactose, corn syrup solids, glucose syrup, hydrogenated glucose syrup, and the like, alone or in combination.
The sweetener can be used in combination with sugarless sweeteners. Generally, sugarless sweeteners include components with sweetening characteristics but which are devoid of the commonly known sugars and comprise, but are not limited to, sugar alcohols, such as sorbitol, mannitol, xylitol, hydrogenated starch hydrolyzates, maltitol, isomalt, erythritol, lactitol and the like, alone or in combination.

PCT/D1(2021/050334 As used herein the term "flavor" is understood as having its ordinary meaning within the art. Flavor includes liquid and powdered flavors. Thus, flavors do of course not include sweeteners (such as sugar, sugar alcohols and high intensity sweeteners), or acids providing pure acidity/sourness, nor compounds providing pure saltiness (e.g.
5 NaCl) or pure bitterness. Flavor enhancers include substances that only provide saltiness, bitterness or sourness. Flavor enhancers thus include e.g. NaCl, Citric acid, ammonium chloride etc.
The flavors can be natural or synthetic flavors.
10 In an embodiment of the invention the pouch composition comprises flavor. Flavor may typically be present in amounts between 0.01 and 15% by weight of the total composition of the pouch, such as between 0.01 and 5% by weight of the total composition.
15 Non-exhaustive examples of flavors suitable in embodiments of the present invention are coconut, coffee, chocolate, vanilla, grape fruit, orange, lime, menthol, liquorice, caramel aroma, honey aroma, peanut, walnut, cashew, hazelnut, almonds, pineapple, strawberry, raspberry, tropical fruits, cherries, cinnamon, peppermint, wintergreen, spearmint, eucalyptus, and mint, fruit essence such as from apple, pear, peach, 20 strawberry, apricot, raspberry, cherry, pineapple, and plum essence. The essential oils include peppermint, spearmint, menthol, eucalyptus, clove oil, bay oil, anise, thyme, cedar leaf oil, nutmeg, and oils of the fruits mentioned above.
In various embodiments of the invention, the pouch composition comprises 25 composition modifier. The composition modifier may be added to engineer the properties of the pouch composition and/or parts thereof, such as flowability, texture, homogeneity etc.
The composition modifiers may, according to various embodiments, be selected 30 group consisting of metallic stearates, modified calcium carbonate, hydrogenated vegetable oils, partially hydrogenated vegetable oils, polyethylene glycols, PCT/D1(2021/050334 polyoxy ethylene monostearates, animal fats, silicates, silicates dioxide, talc, magnesium stearates, calcium stearates, fumed silica, powdered hydrogenated cottonseed oils, hydrogenated vegetable oils, hydrogenated soya oil, emulsifiers, triglycerides, and mixtures thereof Particularly, metallic stearates, such as magnesium stearate, may be advantageous.
The composition modifiers may be added to the pouch composition in various ways.
For example, the composition modifiers may be added by full powder mixture during the last few minutes of the final mixing.
Alternatively, the composition modifiers may be added after granulation steps on a granulation premix.
The composition modifier, such as magnesium stearate, may have a sealing effect and can be used to control the release of the nicotine and the solubility of the pouch.
According to an embodiment of the invention, the pouch composition comprises polyvinylpyrrolidone (PVP). The pouch composition may also be free of PVP.
One advantage of the above embodiment may be that a more uniform composition may be obtained.

PCT/D1(2021/050334 EXAMPLES
Example 1A ¨ Preparation of pouches designed for administration of nicotine The material of the pouches is heat sealable non-woven cellulose, such as long fiber paper. Pouches that are not in form of non-woven cellulose fabric may also be used according to the invention.
The powder is filled into pouches and is maintained in the pouch by a sealing.
Example 1B ¨ Preparation of pouches designed for administration of nicotine The material of the pouches is manufactured using rayon fibers, such as viscose rayon staple fibers. The pouch membrane is heat sealed along its edges except for an opening in one end into an inner cavity formed by the pouch membrane.
The powder is filled into pouches and is maintained in the pouch by a sealing.
Example 2: Preparation of nicotine premixes A 60 liter planetary Bear Varimixer mixer was charged with water, and nicotine was weighed and added. The mixer was stirred at low speed for 1 minute at ambient temperature. Then ion exchange resin Amberlite IRP64 was weighed and added to the mixer. The mixer was closed, stirred at high speed for 5 minutes, opened and scraped down, if necessary. Finally the mixer was stirred for further 5 minutes at high speed. The total process time was 20 minutes.
Thereby, mixtures of nicotine and cation exchange resin were produced from the constituents stated in the below tables.
Premix I:
Constituent Amount (kg) Amount (%) Nicotine 1.0 5.7 Water 12.5 71.4 Resin 4.0 22.9 PCT/D1(2021/050334 Total 17.5 100.0 Table 1. Ingredients used to manufacture nicotine premix I (5.7% nicotine). %
water in obtained nicotine-resin composition: 71.4 Premix II:
Constituent Amount (kg) Amount (%) Nicotine 1.08 13.2 Water 2.80 34.1 Resin 4.32 52.7 Total 8.20 100.0 Table 2. Ingredients used to manufacture nicotine premix II (13.2% nicotine).
9/0 water in obtained nicotine-resin composition: 34.1.
Premix III:
Constituent Amount (kg) Amount (%) Nicotine 1.08 18.5 Water 0.44 7.5 Resin 4.32 74.0 Total 5.84 100.0 Table 3. Ingredients used to manufacture nicotine premix III (18.5% nicotine).
% water in obtained nicotine-resin composition:7.5.
Premix IV:
Constituent Amount (kg) Amount (%) Nicotine 1.08 10.0 Water 5.40 50.0 Resin 4.32 40.0 Total 10.8 100.0 Table 4. Ingredients used to manufacture nicotine premix IV (10% nicotine). %
water in obtained nicotine-resin composition: 50Ø

PCT/D1(2021/050334 Premix V:
Constituent Amount (kg) Amount (%) Nicotine 1.78 20.0 Water 2.80 31.5 Resin 4.32 48.5 Total 8.90 100.0 Table 5. Ingredients used to manufacture nicotine premix V (20% nicotine). %
water in obtained nicotine-resin composition: 31.5.
Premix VI:
Constituent Amount (kg) Amount (%) Nicotine 3.05 30.0 Water 2.80 27.5 Resin 4.32 42.5 Total 10.17 100.0 Table 6. Ingredients used to manufacture nicotine premix VI (30% nicotine). %
water in obtained nicotine-resin composition: 27.5.
Premix VII
Constituent Amount (kg) Amount (%) Nicotine 3.83 35.0 Water 2.80 25.6 Resin 4.32 39.4 Total 10.95 100.0 Table 7. Ingredients used to manufacture nicotine premix VII (35% nicotine).
_______ 0/0 water in obtained nicotine-resin composition: 25.6.
Premix VIII:
Constituent Amount (kg) Amount (%) PCT/D1(2021/050334 Nicotine 5.15 42.0 Water 2.80 22.8 Resin 4.32 35.2 Total 12.27 100.0 Table 8. Ingredients used to manufacture nicotine premix VIII (42% nicotine)..
%
water in obtained nicotine-resin composition: 22.8.
Example 3: Preparation of pouch compositions 5 Pouches are prepared comprising powdered compositions as outlined in table 9 ¨ 21.
The pouches are made as follows.
Fibers and water are mixed using a planetary Bear Varimixer mixer for 5 minutes.
Then, the following ingredients were added subsequently under continuous mixing:
10 first the nicotine-ion exchange combination (NPR or premix) (mixed for 2 minutes), then the remaining ingredients except liquid flavor and glidant if any (mixed for 2 minutes), then liquid flavor if any (mixed for 1 minute), then glidant if any (mixed for 1 minute). The total mixing time is 9-11 minutes.
15 Example 4: Preparation of filled pouches The final pouch composition is filled into pouches (target fill weight 500 mg powder per pouch). The pouch material of example 1A or 1B may be used. The powder is filled into pouches and is maintained in the pouch by a sealing.
20 Example 5A: Pouches The pouch compositions are prepared from the ingredients in table 9 using preparation method described in example 3.
The pouch compositions are filled into pouches as described in example 4 (pouch material of examples lA was used, but 1B could also have been applied).
Pouches POI P02 P03 PO4 P05 P06 P07 P08 Cl PCT/D1(2021/050334 Amount of 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 mg nicotine mg mg mg mg mg mg mg mg Water content 25 25 25 25 25 25 25 25 twtcY01 Inorganic divalent 0.5 0.75 1 1.5 2 3 4 7.5 -cations [eq]*
Raw Content in weight percent material NPR (16%) 12.1 12.1 12.1 12.1 12.1 12.1 12.1 12.1 12.1 CaC12** 0.7 1.0 1.3 2.0 2.6 3.9 5.2 10.0 -Xylitol 18.2 17.9 17.6 16.9 16.3 15.0 13.7 8.9 18.9 Purified water Wheat fiber 25 25 25 25 25 25 25 25 Sodium 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 alginate Sodium 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 carbonate Flavor 8.9 8.9 8.9 8.9 8.9 8.9 8.9 8.9 8.9 High intensity 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 sweetener Potassium 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 sorb ate Silicon 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 dioxide Total 100 100 100 100 100 100 100 100 100 Table 9: Pouch compositions.

PCT/D1(2021/050334 *The inorganic divalent cations is presented as equivalents relative to nicotine in nicotine ion-exchange combination.
**Divalent cations may be provided as a hydrated salt, such as dihydrate, tetrahydrate, hexahydrate etc. The weight% in the table are based on the non-hydrated salt.
Pouch content: 500 mg total, i.e. nicotine conc 19.2 mg/g.
Wheat fiber, trade name "Vitacel 600 WF plus". Other fibers may be used as well, such as water-insoluble plant fibers, such as oat fibers, pea fibers, rice fiber, maize fibers, oat fibers, tomato fibers, barley fibers, rye fibers, sugar beet fibers, buckwheat fibers, potato fibers, cellulose fibers, apple fibers, cocoa fibers, powdered cellulose, bran fibers, bamboo fibers, and cellulose fiber.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may also be used in combination with sodium alginate, glycerol or HPC or as an alternative.
Sodium carbonate is used as an alkaline buffering agent. Other buffering agents as described herein may also be used in combination with sodium carbonate or an alternative.
Flavor example, a mixture of e.g. menthol and peppermint may be used. Of course, other flavors as described herein may be use as well, in combination with menthol and/or peppermint or replacing these. The flavor may be liquid or flavored or a combination, i.e. a liquid flavor and a powdered flavor is added.
Acesulfame potassium and/or sucralose may as an example be used as high intensity sweeteners. Other usable high intensity sweeteners described herein may be used in combination with or instead of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may also be used in combination with or instead of potassium sorbate.
Silicon dioxide is used as a glidant. Other possible glidants include e.g.
magnesium stearate, starch and talc.
Example 5B:

PCT/D1(2021/050334 The pouch compositions are prepared from the ingredients in table 10 using preparation method described in example 3.
The pouch compositions are filled into pouches as described in example 4 (pouch material of examples lA was used, but 1B could also have been applied).

Pouches P12 P13 P14 P15 P16 P17 P18 C2 C3 Amount of 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 nicotine mg mg mg mg mg mg mg mg mg mg Water content 15 25 30 35 30 30 30 10 25 25 [Art%]
Inorganic divalent 1.0 1.0 1.0 1.0 1.0 1.5 2.0 1.0 -cations [eq]*
Raw material Content in weight percent 12.
NPR (16`)/0) 1 12.1 12.1 12.1 12.1 12.1 12.1 12.1 12.1 12.1 CaCl2** 1.3 1.3 1.3 1.3 - - 1.3 -MgCl2** - 1.1 1.7 2.2 -37.
Xylitol 6 17.6 7.6 2.6 12.8 12.2 11.7 32.6 12.0 18.2 Purified water Wheat fiber 15 25 30 30 25 25 25 25 Sodium 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 alginate Sodium 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 carbonate Flavor 8.9 8.9 8.9 8.9 8.9 8.9 8.9 8.9 8.9 8.9 PCT/D1(2021/050334 6.9 0.7 NaCl ***
***
High intensity 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 sweetener Potassium 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 sorb ate Silicon 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 dioxide Total Table 10: Pouch compositions.
*The inorganic divalent cations are presented as equivalents relative to nicotine in nicotine ion-exchange combination.
**Divalent cations may be provided as a hydrated salt, such as dihydrate, tetrahydrate, hexahydrate etc. The weight% in the table are based on the non-hydrated salt.
***Corresponds to 1 eq of NaC1 relative to nicotine in nicotine ion-exchange combination.
****Corresponds to 10 eq of NaCl relative to nicotine in nicotine ion-exchange combination.
Pouch content: 500 mg total, i.e. nicotine cone 19.2 mg/g.
Wheat fiber, trade name "Vitacel 600 WF plus". Other fibers may be used as well, such as water-insoluble plant fibers, such as oat fibers, pea fibers, rice fiber, maize fibers, oat fibers, tomato fibers, barley fibers, rye fibers, sugar beet fibers, buckwheat fibers, potato fibers, cellulose fibers, apple fibers, cocoa fibers, powdered cellulose, bran fibers, bamboo fibers, and cellulose fiber.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may also be used in combination with sodium alginate, glycerol or HPC or as an alternative.

PCT/D1(2021/050334 Sodium carbonate is used as an alkaline buffering agent. Other buffering agents as described herein may also be used in combination with sodium carbonate or an alternative.
Flavor example, a mixture of e.g. menthol and peppermint may be used. Of course, 5 other flavors as described herein may be use as well, in combination with menthol and/or peppermint or replacing these. The flavor may be liquid or flavored or a combination, i.e. a liquid flavor and a powdered flavor is added.
Acesulfame potassium and/or sucralose may as an example be used as high intensity sweeteners. Other usable high intensity sweeteners described herein may be used in 10 combination with or instead of acesul fame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may also be used in combination with or instead of potassium sorbate.
Silicon dioxide is used as a glidant. Other possible glidants include e.g.
magnesium stearate, starch and talc.
Example SC:
The pouch compositions are prepared from the ingredients in table 11 using preparation method described in example 3.
The pouch compositions are filled into pouches as described in example 4 (pouch material of examples lA was used, but 1B could also have been applied).
Pouches 9.6 9.6 9.6 9.6 9.6 9.6 9.6 4.8 7.2 12.0 Amount of nicotine mg mg mg mg mg mg mg mg mg mg Water content [wt%]
Inorganic cations 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 [eq]*
Raw material Content in weight percent NPR (16%) 12.1 12.1 12.1 12.1 12.1 12.1 12.1 6.1 9.0 15.1 PCT/D1(2021/050334 CaCl2** - - -- 0.7 1.0 1.6 Calcium acetate** 1.9 - -Magnesium - 1.7 -acetate**
Calcium lactate** - - 2.6 - - -- -Magnesium - 2.4 -lactate**
FeCl2** - - 1.5 -ZnC12** - 1.6 - -A1C13** - - - - - 1.6 -- -Xylitol 11.0 11.2 10.3 10.5 11.4 11.3 11.3 18.2 15.0 8.3 Purified water 28 28 28 28 28 28 28 Wheat fiber 28 28 28 28 28 28 28 Sodium alginate 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Sodium carbonate 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 Flavor 8.9 8.9 8.9 8.9 8.9 8.9 8.9 8.9 8.9 8.9 High intensity 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 sweetener Potassium sorbate 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Silicon dioxide 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Total 100 100 100 100 100 100 100 100 100 100 Table 11: Pouch compositions.
*The inorganic cations are presented as equivalents relative to nicotine in nicotine ion-exchange combination.
**Multivalent cations may be provided as a hydrated salt, such as dihydrate, tetrahydrate, hexahydrate etc. The weight% in the table are based on the non-hydrated salt.
Pouch content: 500 mg total.

PCT/D1(2021/050334 Wheat fiber, trade name "Vitacel 600 WF plus". Other fibers may be used as well, such as water-insoluble plant fibers, such as oat fibers, pea fibers, rice fiber, maize fibers, oat fibers, tomato fibers, barley fibers, rye fibers, sugar beet fibers, buckwheat fibers, potato fibers, cellulose fibers, apple fibers, cocoa fibers, powdered cellulose, bran fibers, bamboo fibers, and cellulose fiber.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may also be used in combination with sodium alginate, glycerol or UPC or as an alternative.
Sodium carbonate is used as an alkaline buffering agent. Other buffering agents as described herein may also be used in combination with sodium carbonate or an alternative.
Flavor example, a mixture of e.g. menthol and peppermint may be used. Of course, other flavors as described herein may be use as well, in combination with menthol and/or peppermint or replacing these. The flavor may be liquid or flavored or a combination, i.e. a liquid flavor and a powdered flavor is added.
Acesulfame potassium and/or sucralose may as an example be used as high intensity sweeteners. Other usable high intensity sweeteners described herein may be used in combination with or instead of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may also be used in combination with or instead of potassium sorbate.
Silicon dioxide is used as a glidant. Other possible glidants include e.g.
magnesium stearate, starch and talc.
Example 5D:
The pouch compositions are prepared from the ingredients in table 12 using preparation method described in example 3.
The pouch compositions are filled into pouches as described in example 4 (pouch material of examples lA was used, but 1B could also have been applied).
Pouches P30 P31 P32 P33 P34 P35 P36 P37 P38 P39 Amount of 9.6 9.6 9.6 9.6 9.6 9.6 9.6 4.8 7.2 12.0 nicotine mg mg mg mg mg mg mg mg mg mg PCT/D1(2021/050334 Water content [wt%]
Inorganic 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 cations [eq]*
Raw material Content in weight percent Premix VI 6.4 6.4 6.4 6.4 6.4 6.4 6.4 3.2 4.8 8.0 CaCl2** - - - - 0.7 1.0 1.6 Calcium 1.9 - - - -acetate**
Magnesium - 1.7 - - -acetate**
Calcium - - 2.6 - -lactate**
Magnesium - 2.4 -lactate**
FeC12** - - 1.5 -ZnC12** - - - 1.6 -A1C13** - - - - 1.6 -Xylitol 18.7 18.9 18.0 18.2 19.1 19.0 19.0 21.9 20.5 17.6 Purified water 26 26 26 26 26 26 26 27.2 26.7 25.8 Wheat fiber 28 28 28 28 28 28 28 28 28 28 Sodium alginate 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Sodium 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 carbonate Flavor 8.9 8.9 8.9 8.9 8.9 8.9 8.9 8.9 8.9 8.9 High intensity 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 sweetener Potassium 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 sorb ate Silicon dioxide 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 PCT/D1(2021/050334 Total 100 100 100 100 100 100 100 100 100 100 Table 12: Pouch compositions.
*The inorganic cations are presented as equivalents relative to nicotine in nicotine ion-exchange combination.
**Multivalent cations may be provided as a hydrated salt, such as dihydrate, tetrahydrate, hexahydrate etc. The weight% in the table are based on the non-hydrated salt.
Pouch content: 500 mg total.
Wheat fiber, trade name "Vitacel 600 WF plus". Other fibers may be used as well, such as water-insoluble plant fibers, such as oat fibers, pea fibers, rice fiber, maize fibers, oat fibers, tomato fibers, barley fibers, rye fibers, sugar beet fibers, buckwheat fibers, potato fibers, cellulose fibers, apple fibers, cocoa fibers, powdered cellulose, bran fibers, bamboo fibers, and cellulose fiber.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may also be used in combination with sodium alginate, glycerol or HPC or as an alternative.
Sodium carbonate is used as an alkaline buffering agent. Other buffering agents as described herein may also be used in combination with sodium carbonate or an alternative.
Flavor example, a mixture of e.g. menthol and peppermint may be used. Of course, other flavors as described herein may be use as well, in combination with menthol and/or peppermint or replacing these. The flavor may be liquid or flavored or a combination, i.e. a liquid flavor and a powdered flavor is added.
Acesulfame potassium and/or sucralose may as an example be used as high intensity sweeteners. Other usable high intensity sweeteners described herein may be used in combination with or instead of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may also be used in combination with or instead of potassium sorbate.
Silicon dioxide is used as a glidant. Other possible glidants include e.g magnesium stearate, starch and talc.

PCT/D1(2021/050334 Example 5E:
The pouch compositions are prepared from the ingredients in table 13 using preparation method described in example 3.
5 The pouch compositions are filled into pouches as described in example 4 (pouch material of examples lA was used, but 1B could also have been applied).
Pouches P40 P41 P42 P43 P44 P45 C4 C5 Amount of 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 nicotine mg mg mg mg mg mg mg mg Water content [wt%]
Inorganic divalent 0.75 1.0 1.5 0.75 1.0 1.5 cations [eq]*
Raw material Content in weight percent Premix II 14.6 14.6 14.6 - -14.6 -Premix VI 6.4 6.4 6.4 6.4 CaCl2** 1.0 1.3 2.0 1.0 1.3 2.0 Xylitol 10.4 10.1 9.4 15.6 15.3 14.6 9.4 14.6 Purified water 25 25 25 28 28 28 25 Wheat fiber 30 30 30 30 30 30 30 Sodium alginate 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Sodium carbonate 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 NaC1 2.0 2.0 Flavor 8.9 8.9 8.9 8.9 8.9 8.9 8.9 8.9 High intensity 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 sweetener Potassium sorbate 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Silicon dioxide 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Total 100 100 100 100 100 100 Table 13: Pouch compositions.

PCT/D1(2021/050334 *The inorganic divalent cations are presented as equivalents relative to nicotine in nicotine ion-exchange combination.
**Divalent cations may be provided as a hydrated salt, such as dihydrate, tetrahydrate, hexahydrate etc. The weight% in the table are based on the non-hydrated salt.
Pouch content: 500 mg total, i.e. nicotine cone 19.2 mg/g.
Wheat fiber, trade name "Vitacel 600 WF plus". Other fibers may be used as well, such as water-insoluble plant fibers, such as oat fibers, pea fibers, rice fiber, maize fibers, oat fibers, tomato fibers, barley fibers, rye fibers, sugar beet fibers, buckwheat fibers, potato fibers, cellulose fibers, apple fibers, cocoa fibers, powdered cellulose, bran fibers, bamboo fibers, and cellulose fiber.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may also be used in combination with sodium alginate, glycerol or HPC or as an alternative.
Sodium carbonate is used as an alkaline buffering agent. Other buffering agents as described herein may also be used in combination with sodium carbonate or an alternative.
Flavor example, a mixture of e.g. menthol and peppermint may be used. Of course, other flavors as described herein may be use as well, in combination with menthol and/or peppermint or replacing these. The flavor may be liquid or flavored or a combination, i.e. a liquid flavor and a powdered flavor is added.
Acesulfame potassium and/or sucralose may as an example be used as high intensity sweeteners. Other usable high intensity sweeteners described herein may be used in combination with or instead of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may also be used in combination with or instead of potassium sorbate.
Silicon dioxide is used as a glidant. Other possible glidants include e.g.
magnesium stearate, starch and talc.
Example 5F:
The pouch compositions are prepared from the ingredients in table 14 using preparation method described in example 3.

PCT/D1(2021/050334 The pouch compositions are filled into pouches as described in example 4 (pouch material of examples 1A was used, but 1B could also have been applied).
Pouches 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 Amount of nicotine mg mg mg mg mg mg mg mg Water content [wf%]
Inorganic divalent 1.0 1.0 1.0 1.0 1.0 1.0 cations [eq]*
Raw material Content in weight percent Premix VI 6.4 6.4 6.4 6.4 Premix VII 5.5 5.5 Premix VIII 4.6 4.6 CaCl2** 1.3 1.3 1.3 1.3 1.3 1.3 Xylitol 45.3 25.3 4.3 15.6 16.1 49.3 21.9 17.4 Purified water 13 23 38 28.6 29 9 28.6 29 Wheat fiber 15 25 31 30 30 15 25 Sodium alginate 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Sodium carbonate 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 Flavor 8.9 8.9 8.9 8.9 8.9 8.9 8.9 8.9 High intensity 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 sweetener Potassium sorbate 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Silicon dioxide 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Total 100 100 100 100 100 Table 14: Pouch compositions.
*The inorganic divalent cations is presented as equivalents relative to nicotine in nicotine ion-exchange combination.
**Divalent cations may be provided as a hydrated salt, such as dihydrate, tetrahydrate, hexahydrate etc. The weight% in the table are based on the non-hydrated salt.

PCT/D1(2021/050334 Pouch content: 500 mg total, i.e. nicotine conc 19.2 mg/g.
Wheat fiber, trade name "Vitacel 600 WF plus". Other fibers may be used as well, such as water-insoluble plant fibers, such as oat fibers, pea fibers, rice fiber, maize fibers, oat fibers, tomato fibers, barley fibers, rye fibers, sugar beet fibers, buckwheat fibers, potato fibers, cellulose fibers, apple fibers, cocoa fibers, powdered cellulose, bran fibers, bamboo fibers, and cellulose fiber.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may also be used in combination with sodium alginate, glycerol or TIPC or as an alternative.
Sodium carbonate is used as an alkaline buffering agent. Other buffering agents as described herein may also be used in combination with sodium carbonate or an alternative.
Flavor example, a mixture of e.g. menthol and peppermint may be used. Of course, other flavors as described herein may be use as well, in combination with menthol and/or peppermint or replacing these. The flavor may be liquid or flavored or a combination, i.e. a liquid flavor and a powdered flavor is added.
Acesulfame potassium and/or sucralose may as an example be used as high intensity sweeteners. Other usable high intensity sweeteners described herein may be used in combination with or instead of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may also be used in combination with or instead of potassium sorbate.
Silicon dioxide is used as a glidant. Other possible glidants include e.g.
magnesium stearate, starch and talc.
Example 5G:
The pouch compositions are prepared from the ingredients in table 15 using preparation method described in example 3.
The pouch compositions are filled into pouches as described in example 4 (pouch material of examples lA was used, but 1B could also have been applied).
Pouches P60 P61 P62 P63 P64 P65 P66 P67 C8 C9 WO 2022/100805 PCT/D1(2021/050334 Amount of 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 nicotine mg mg mg mg mg mg mg mg mg mg Water content 27 27 27 27 27 27 35 30 30 30 twt%]
Inorganic divalent 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 -cations [eq]*
Raw Content in weight percent material Premix VI 6.4 6.4 6.4 6.4 6.4 6.4 6.4 6.4 6.4 6.4 CaC12** 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 -Xylitol 5.0 - - 7.0 - 5.0 5.0 5.0 Isomalt - 21.3 -Sorbitol - 21.3 -Mannitol - 21.3 -Maltitol - 21.3 -Erythritol 16.3 - - 14.3 - 14.2 23.5 18.5 Purified water Wheat fiber 27 27 27 27 27 27 40.3 30 15 15 Sodium 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 alginate Sodium 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 carbonate Flavor 8.9 8.9 8.9 8.9 8.9 8.9 8.9 5.0 7.0 7.0 NaC1 - 5.0 10.0 PCT/D1(2021/050334 High intensity 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 sweetener Potassium 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 sorb ate Silicon 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 dioxide Total 100 100 100 100 100 100 100 100 100 100 Table 15: Pouch compositions.
*The inorganic divalent cations is presented as equivalents relative to nicotine in nicotine ion-exchange combination.
**Divalent cations may be provided as a hydrated salt, such as dihydrate, tetrahydrate, 5 hexahydrate etc. The weight% in the table are based on the non-hydrated salt.
Pouch content: 500 mg total, i.e. nicotine cone 19.2 mg/g.
Wheat fiber, trade name "Vitacel 600 WF plus". Other fibers may be used as well, such as water-insoluble plant fibers, such as oat fibers, pea fibers, rice fiber, maize 10 fibers, oat fibers, tomato fibers, barley fibers, rye fibers, sugar beet fibers, buckwheat fibers, potato fibers, cellulose fibers, apple fibers, cocoa fibers, powdered cellulose, bran fibers, bamboo fibers, and cellulose fiber.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may also be used in combination 15 with sodium alginate, glycerol or HPC or as an alternative.
Sodium carbonate is used as an alkaline buffering agent. Other buffering agents as described herein may also be used in combination with sodium carbonate or an alternative.
Flavor example, a mixture of e.g. menthol and peppermint may be used. Of course, 20 other flavors as described herein may be use as well, in combination with menthol and/or peppermint or replacing these. The flavor may be liquid or flavored or a combination, i.e. a liquid flavor and a powdered flavor is added.

PCT/D1(2021/050334 Acesulfame potassium and/or sucralose may as an example be used as high intensity sweeteners. Other usable high intensity sweeteners described herein may be used in combination with or instead of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may also be used in combination with or instead of potassium sorbate.
Silicon dioxide is used as a glidant. Other possible glidants include e.g.
magnesium stearate, starch and talc.
Example 5H:
The pouch compositions are prepared from the ingredients in table 16 using preparation method described in example 3.
The pouch compositions are filled into pouches as described in example 4 (pouch material of examples lA was used, but 1B could also have been applied).
Pouches 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 Amount of nicotine mg mg mg mg mg mg mg mg Water content [wt%] 27 27 27 20 20 Inorganic divalent cations 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 [eq]*
Raw material Content in weight percent Premix VI 6.4 6.4 6.4 6.4 6.4 6.4 6.4 6.4 CaCl2** 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 Xylitol 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 Erythritol 18.2 18.2 18.2 42.2 22.2 17.2 22.2 17.2 Purified water 25 25 25 18 18 33 18 33 Wheat fiber 10 30 20 Oat fiber 27 Pea Fiber 27 Powdered Cellulose 27 Sodium alginate 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 PCT/D1(2021/050334 Sodium carbonate 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 Flavor 7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0 High intensity sweetener 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 Potassium sorbate 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Silicon dioxide 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Total 100 100 100 100 100 100 100 100 Table 16: Pouch compositions.
*The inorganic divalent cations is presented as equivalents relative to nicotine in nicotine ion-exchange combination.
**Divalent cations may be provided as a hydrated salt, such as dihydrate, tetrahydrate, hexahydrate etc. The weight% in the table are based on the non-hydrated salt.
Pouch content: 500 mg total, i.e. nicotine conc 19.2 mg/g.
Wheat fiber, trade name "Vitacel 600 WF plus" or "Vitacel 200WF".
Powdered cellulose, trade name "Vitacel LOU" or "Vitacel L700G".
Oat fiber, trade name "Vitacel HF 600".
Pea fiber, trade name "Vitacel EF150".
Other fibers may be used as well, such as water-insoluble plant fibers, such as oat fibers, pea fibers, rice fiber, maize fibers, oat fibers, tomato fibers, barley fibers, rye fibers, sugar beet fibers, buckwheat fibers, potato fibers, powdered cellulose, cellulose fibers, apple fibers, cocoa fibers, bamboo fibers, bran fibers, and cellulose fiber.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may also be used in combination with sodium alginate, glycerol or HPC or as an alternative.
Sodium carbonate is used as an alkaline buffering agent. Other buffering agents as described herein may also be used in combination with sodium carbonate or an alternative.
Flavor example, a mixture of e.g. menthol and peppermint may be used. Of course, other flavors as described herein may be use as well, in combination with menthol PCT/D1(2021/050334 and/or peppermint or replacing these. The flavor may be liquid or flavored or a combination, i.e. a liquid flavor and a powdered flavor is added.
Acesulfame potassium and/or sucralose may as an example be used as high intensity sweeteners. Other usable high intensity sweeteners described herein may be used in combination with or instead of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may also be used in combination with or instead of potassium sorbate.
Silicon dioxide is used as a glidant. Other possible glidants include e.g.
magnesium stearate, starch and talc.
Example 51:
The pouch compositions are prepared from the ingredients in table 17 using preparation method described in example 3.
The pouch compositions are filled into pouches as described in example 4 (pouch material of examples lA was used, but 1B could also have been applied).
Pouches P80 P81 P82 P83 P84 P85 P86 P87 P88 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 Amount of nicotine mg mg mg mg mg mg mg mg mg Water content [wt%]
Inorganic divalent 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 cations [eq]*
Raw material Content in weight percent NPR (16%) 12.1 12.1 12.1 12.1 12.1 12.1 12.1 12.1 12.1 CaCl2** 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 Xylitol 5.0 5.0 5.0 5.0 Isomalt 13.5 Sorbitol 13.5 Mannitol 13.5 Maltitol 13.5 PCT/D1(2021/050334 Erythritol 8.5 - - 8.5 8.5 8.5 Purified water 28 28 28 28 28 35 28 Wheat fiber 28 28 28 28 28 34.5 -Oat fiber 28 Pea Fiber 28 Powdered Cellulose Sodium alginate 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Sodium carbonate 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 Flavor 7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0 7.0 High intensity 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 sweetener Potassium sorbate 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Silicon dioxide 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Total 100 100 100 100 100 100 100 100 100 Table 17: Pouch compositions.
*The inorganic divalent cations are presented as equivalents relative to nicotine in nicotine ion-exchange combination.
**Divalent cations may be provided as a hydrated salt, such as dihydrate, tetrahydrate, hexahydrate etc. The weight% in the table are based on the non-hydrated salt.
Pouch content: 500 mg total, i.e. nicotine conc 19.2 mg/g.
Wheat fiber, trade name "Vitacel 600 WF plus" or "Vitacel 200WF".
Powdered cellulose, trade name "Vitacel LOO" or "Vitacel L700G".
Oat fiber, trade name "Vitacel HF 600".
Pea fiber, trade name "Vitacel EF150".
Other fibers may be used as well, such as water-insoluble plant fibers, such as oat fibers, pea fibers, rice fiber, maize fibers, oat fibers, tomato fibers, barley fibers, rye fibers, sugar beet fibers, buckwheat fibers, potato fibers, powdered cellulose, cellulose fibers, apple fibers, cocoa fibers, bamboo fibers, bran fibers, and cellulose fiber.

PCT/D1(2021/050334 Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may also be used in combination with sodium alginate, glycerol or HPC or as an alternative.
Sodium carbonate is used as an alkaline buffering agent. Other buffering agents as 5 described herein may also be used in combination with sodium carbonate or an alternative.
Flavor example, a mixture of e.g. menthol and peppermint may be used. Of course, other flavors as described herein may be use as well, in combination with menthol and/or peppermint or replacing these. The flavor may be liquid or flavored or a 10 combination, i.e. a liquid flavor and a powdered flavor is added.
Acesulfame potassium and/or sucralose may as an example be used as high intensity sweeteners. Other usable high intensity sweeteners described herein may be used in combination with or instead of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein 15 may also be used in combination with or instead of potassium sorbate.
Silicon dioxide is used as a glidant. Other possible glidants include e.g magnesium stearate, starch and talc.
Example 5J:
20 The pouch compositions are prepared from the ingredients in table 18 using preparation method described in example 3.
The pouch compositions are filled into pouches as described in example 4 (pouch material of examples lA was used, but 1B could also have been applied).
Pouches Amount of 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 nicotine mg mg mg mg mg mg mg mg mg Water content [wt%]
Inorganic divalent 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 cations [eq]*

PCT/D1(2021/050334 Raw material Content in weight percent NPR (16%) 7.0 12.1 12.1 12A 12A
12.1 12.1 12.1 12.1 NBT 2.3 -CaCl2** 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 Xylitol 10.4 10.1 8.6 11.6 11.6 12.6 7.6 7.6 11.5 Purified water 30 30 27 27 27 30 30 Wheat fiber 30 30 27 27 27 30 30 Sodium alginate 2.0 2.0 2.0 2.0 2.0 2.0 -Glycerol - 2.0 -Hydroxypropyl cellulose Sodium carbonate 5.0 2.5 10.0 3.5 - -5.0 5.0 5.0 Sodium hydrogen-carbonate Trometamol - 7.0 -Flavor 8.9 8.9 8.9 8.9 8.9 8.9 8.9 8.9 7.0 High intensity 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 sweetener Potassium sorbate 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Silicon dioxide 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Total 100 100 100 100 100 100 100 100 100 Table 18: Pouch compositions.
*The inorganic divalent cations are presented as equivalents relative to nicotine in nicotine ion-exchange combination.
**Divalent cations may be provided as a hydrated salt, such as dihydrate, tetrahydrate, hexahydrate etc. The weight% in the table are based on the non-hydrated salt.
Pouch content: 500 mg total, i.e. nicotine conc 19.2 mg/g.
Wheat fiber, trade name "Vitacel 600 WF plus". Other fibers may be used as well, such as water-insoluble plant fibers, such as oat fibers, pea fibers, rice fiber, maize PCT/D1(2021/050334 fibers, oat fibers, tomato fibers, barley fibers, rye fibers, sugar beet fibers, buckwheat fibers, potato fibers, cellulose fibers, apple fibers, cocoa fibers, powdered cellulose, bran fibers, bamboo fibers, and cellulose fiber.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may also be used in combination with sodium alginate, glycerol or HPC or as an alternative.
Sodium carbonate is used as an alkaline buffering agent. Other buffering agents as described herein may also be used in combination with sodium carbonate or an alternative.
Flavor example, a mixture of e.g. menthol and peppermint may be used. Of course, other flavors as described herein may be use as well, in combination with menthol and/or peppermint or replacing these. The flavor may be liquid or flavored or a combination, i.e. a liquid flavor and a powdered flavor is added.
Acesulfame potassium and/or sucralose may as an example be used as high intensity sweeteners. Other usable high intensity sweeteners described herein may be used in combination with or instead of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may also be used in combination with or instead of potassium sorbate.
Silicon dioxide is used as a glidant. Other possible glidants include e.g.
magnesium stearate, starch and talc.
Example 5K:
The pouch compositions are prepared from the ingredients in table 19 using preparation method described in example 3.
The pouch compositions are filled into pouches as described in example 4 (pouch material of examples lA was used, but 1B could also have been applied).
Pouches Amount of 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 nicotine mg mg mg mg mg mg mg mg mg PCT/D1(2021/050334 Water content rwt%1 Inorganic divalent 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 cations [eq]*
Raw material Content in weight percent Premix VI 3.7 6.4 6.4 6.4 6.4 6.4 6.4 6.4 6.4 NBT 2.3 -CaCl2** 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 1.3 Xylitol 14.7 17.8 13.3 16.3 16.3 20.3 15.3 15.3 17.3 Purified water 29 28 25 25 25 28 28 Wheat fiber 30 30 30 30 30 30 30 Sodium alginate 2.0 2.0 2.0 2.0 2.0 2.0 -Glycerol - 2.0 -Hydroxypropyl cellulose Sodium carbonate 5.0 2.5 10.0 3.5 - -5.0 5.0 5.0 Sodium - 3.5 -hydrogencarbonate Trometamol - 7.0 -Flavor 8.9 8.9 8.9 8.9 8.9 8.9 8.9 8.9 8.9 High intensity 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 sweetener Potassium sorbate 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Silicon dioxide 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 Total 100 100 100 100 100 100 100 100 100 Table 19: Pouch compositions.
*The inorganic divalent cations are presented as equivalents relative to nicotine in nicotine ion-exchange combination.
**Divalent cations may be provided as a hydrated salt, such as dihydrate, tetrahydrate, hexahydrate etc. The weight% in the table are based on the non-hydrated salt.

PCT/D1(2021/050334 Pouch content: 500 mg total, i.e. nicotine conc 19.2 mg/g.
Wheat fiber, trade name "Vitacel 600 WF plus". Other fibers may be used as well, such as water-insoluble plant fibers, such as oat fibers, pea fibers, rice fiber, maize fibers, oat fibers, tomato fibers, barley fibers, rye fibers, sugar beet fibers, buckwheat fibers, potato fibers, cellulose fibers, apple fibers, cocoa fibers, powdered cellulose, bran fibers, bamboo fibers, and cellulose fiber.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may also be used in combination with sodium alginate, glycerol or TIPC or as an alternative.
Sodium carbonate is used as an alkaline buffering agent. Other buffering agents as described herein may also be used in combination with sodium carbonate or an alternative.
Flavor example, a mixture of e.g. menthol and peppermint may be used. Of course, other flavors as described herein may be use as well, in combination with menthol and/or peppermint or replacing these. The flavor may be liquid or flavored or a combination, i.e. a liquid flavor and a powdered flavor is added.
Acesulfame potassium and/or sucralose may as an example be used as high intensity sweeteners. Other usable high intensity sweeteners described herein may be used in combination with or instead of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may also be used in combination with or instead of potassium sorbate.
Silicon dioxide is used as a glidant. Other possible glidants include e.g.
magnesium stearate, starch and talc.
Example 5L:
The pouch compositions are prepared from the ingredients in table 20 using preparation method described in example 3.
The pouch compositions are filled into pouches as described in example 4 (pouch material of examples lA was used, but 1B could also have been applied).

WO 2022/100805 PCT/D1(2021/050334 P P PP P P P P
Pouches C10 C11 C12 Amount 9.6 9.6 9.6 9.6 9.6 9.6 8.0 8.0 9.6 9.6 8.0 of mg mg mg mg mg mg mg mg mg mg mg nicotine Water content 30 30 30 30 30 30 29 29 30 30 29 twt%]
Inorga-nic divalent 0.75 1.0 1.5 0.75 1.0 1.5 2.0 5.0 -cations [eq]*
Raw Content in weight percent material Premix 14.6 14.6 14.6 -- 12.1 12.1 14.6 - 12.1 II
Premix - 6.4 6.4 6.4 - - 6.4 -VI
CaC12** 1.0 1.3 2.0 1.0 1.3 2.0 2.2 5.5 -Xylitol 12.4 12.1 11.4 17.6 17.3 16.6 5.0 5.0 13.4 18.6 5.0 Erythri-- 13.3 6.2 - - 16.9 to!
Purified water Wheat fiber PCT/D1(2021/050334 Powde-red Cellu-lose Sodium carbo- 5.0 5.0 5.0 5.0 5.0 5.0 4.4 8.2 5.0 5.0 3.0 nate Flavor 8.9 8.9 8.9 8.9 8.9 8.9 4.9 4.9 8.9 8.9 4.9 High intensity 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 sweete-ner Potas-sium 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 sorb ate Silicon 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 dioxide Total 100 100 100 100 100 100 100 100 100 100 100 Table 20: Pouch compositions.
*The inorganic divalent cations are presented as equivalents relative to nicotine in nicotine ion-exchange combination.
**Divalent cations may be provided as a hydrated salt, such as dihydrate, tetrahydrate, hexahydrate etc. The weight% in the table are based on the non-hydrated salt.
Pouch content: 500 mg total, i.e. nicotine cone 19.2 mg/g (16 mg/g for samples P116, P117 and C12).
Wheat fiber, trade name "Vitacel 600 WF plus". Powdered Cellulose, trade name "Powdered Cellulose L700G". Other fibers may be used as well, such as water-insoluble plant fibers, such as oat fibers, pea fibers, rice fiber, maize fibers, oat fibers, tomato fibers, barley fibers, rye fibers, sugar beet fibers, buckwheat fibers, potato PCT/D1(2021/050334 fibers, cellulose fibers, apple fibers, cocoa fibers, bran fibers, bamboo fibers, and cellulose fiber.
Sodium carbonate is used as an alkaline buffering agent. Other buffering agents as described herein may also be used in combination with sodium carbonate or an alternative.
Flavor example, a mixture of e.g. menthol and peppermint may be used. Of course, other flavors as described herein may be use as well, in combination with menthol and/or peppermint or replacing these. The flavor may be liquid or flavored or a combination, i.e. a liquid flavor and a powdered flavor is added.
Acesulfame potassium and/or sucralose may as an example be used as high intensity sweeteners. Other usable high intensity sweeteners described herein may be used in combination with or instead of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may also be used in combination with or instead of potassium sorbate.
Silicon dioxide is used as a glidant. Other possible glidants include e.g.
magnesium stearate, starch and talc.
Example 51µ1:
The pouch compositions are prepared from the ingredients in table 21 using preparation method described in example 3.
The pouch compositions are filled into pouches as described in example 4 (pouch material of examples lA was used, but 1B could also have been applied).
Pouches Amount 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 9.6 of mg mg mg mg mg mg mg mg mg mg nicotine Water content 30 30 30 30 30 30 27 27 27 27 [wt.%]

PCT/D1(2021/050334 Inorganic divalent 2.0 3.0 4.0 2.0 3.0 4.0 7.5 7.5 7.5 7.5 cations [eg]*
Raw Content in weight percent material Premix II 14.6 14.6 14.6 - - 14.6 -Premix 6.4 6.4 6.4 - 6.4 6.4 6.4 VI
CaCl2** 2.6 3.9 5.2 2.6 3.9 5.2 10.0 10.0 10.0 10.0 Xylitol 8.8 7.5 6.2 14.0 12.7 11.4 7.4 12.6 11.0 8.5 Purified water Wheat fiber Sodium 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 alginate Sodium 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 carbonate Flavor 8.9 8.9 8.9 8.9 8.9 8.9 8.9 8.9 10.5 13.0 High intensity 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 sweetener Potassiu 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 m sorbate Silicon 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 dioxide Total 100 100 100 100 100 100 100 100 100 100 Table 21: Pouch compositions.
*The inorganic divalent cations are presented as equivalents relative to nicotine in nicotine ion-exchange combination.

PCT/D1(2021/050334 **Divalent cations may be provided as a hydrated salt, such as dihydrate, tetrahydrate, hexahydrate etc. The weight% in the table are based on the non-hydrated salt.
Pouch content: 500 mg total, i.e. nicotine cone 19.2 mg/g.
Wheat fiber, trade name "Vitacel 600 WF plus-. Other fibers may be used as well, such as water-insoluble plant fibers, such as oat fibers, pea fibers, rice fiber, maize fibers, oat fibers, tomato fibers, barley fibers, rye fibers, sugar beet fibers, buckwheat fibers, potato fibers, cellulose fibers, apple fibers, cocoa fibers, powdered cellulose, bran fibers, bamboo fibers, and cellulose fiber.
Sodium alginate, glycerol and hydroxypropyl cellulose (HPC) may be used as humectants. Other humectants as described herein may also be used in combination with sodium alginate, glycerol or HPC or as an alternative.
Sodium carbonate is used as an alkaline buffering agent. Other buffering agents as described herein may also be used in combination with sodium carbonate or an alternative.
Flavor example, a mixture of e.g. menthol and peppermint may be used. Of course, other flavors as described herein may be use as well, in combination with menthol and/or peppermint or replacing these. The flavor may be liquid or flavored or a combination, i.e. a liquid flavor and a powdered flavor is added.
Acesulfame potassium and/or sucralose may as an example be used as high intensity sweeteners. Other usable high intensity sweeteners described herein may be used in combination with or instead of acesulfame potassium and/or sucralose.
Potassium sorbate is used as a preservative. Other preservatives as described herein may also be used in combination with or instead of potassium sorbate.
Silicon dioxide is used as a glidant. Other possible glidants include e.g.
magnesium stearate, starch and talc.
Example 6A: Release experiment and varying salts.
The release experiment was performed by adding an amount of NPR (16%) and varying equivalent of CaCl2 to 900 mL of water corresponding to a nicotine concentration of 28 mg/L. The equivalents of CaCl2 are relative to nicotine.
The PCT/D1(2021/050334 temperature of the water was 25 degrees Celsius throughout the experiment and stirring of 100 rpm was applied throughout the experiment. pH was measured at experiment start and end. The pH was in all experiments below 7.0 at both the start and end of the experiment.
5 A relative low nicotine concentration is used in order to reduce the impact of equilibrium on both the release rate and effective release of nicotine from the ion-exchange resin.
Samples were taken out at varying timepoints and analyzed for nicotine content using standard HPLC. The results are presented as percentage of nicotine released.
No 1 eq 10 eq 1 eq 10 eq Salt Salt NaCl NaC1 CaC12 CaCl2 Minutes Released nicotine (%) 1 12.4 - - 46.3 -2 15.9 24.4 43.8 - 80.3 3 - - 58.4 4 18.1 - - - -8 20.2 - 69.2 11 20.9 - - 72.6 -13 - 28.1 51.9 89.9 14 21.8 - - 75.0 -17 22.4 - - 76.5 -20 23.1 - 78.2 23 - 29.9 52.9 25 24.0 - - -30 24.8 - - -33 - 30.1 54.5 90.4 35 25.7 - - -40 26.5 - - -45 27.2 - - 81.1 -PCT/D1(2021/050334 60 28.8 82.0 Table 22: Release of nicotine over time in the presence of varying salts and varying equivalents of cations.
Evaluation: the result shows that the presence of CaCl2 significantly increases the release of nicotine from NPR. Increasing the amount of CaCl2 result in an increased release of nicotine. The presence of CaCl2 increases both the initial release rate and seems to also increase the effective release of nicotine.
Furthermore, the results show that NaCl has a much lower effect on the release of nicotine, thus high amount of NaCl are needed in order to achieve comparable release of nicotine in the presence of for example 1 eq. of CaCl2.
Example 6B: Release experiment using NPR and varying equivalents of CaCl2.
The release experiment was performed by adding NPR (16%) and varying equivalent of CaCl2 to a volume of water corresponding to a nicotine concentration of 28 mg/L.
The equivalents of CaCl2 are relative to nicotine. The temperature of the water was 25 degrees Celsius throughout the experiment and stirring of 100 rpm was applied throughout the experiment. pH was measured at experiment start and end. The pH
was in all experiments below 7.0 at both the start and end of the experiment.
A relative low nicotine concentration is used in order to reduce the impact of equilibrium on both the release rate and effective release of nicotine from the ion-exchange resin.
Samples were taken out at varying timepoints and analyzed for nicotine content using standard HPLC. The result is presented as percentage of nicotine released.
0.25 0.5 CaCl2 0 eq 0.1 eq 0.75 eq 1 eq 4 eq eq eq Minutes Released nicotine (%) 1 12.4 17.7 25.0 30.5 38.5 46.3 59.1 2 15.9 22.0 39.7 PCT/D1(2021/050334 3 - - 33.9 - 51.7 58.4 71.8 4 18.1 24.3 46.1 - - 38.6 - - 59.3 76.8 7 - - 42.4 - - 64.0 -8 20.2 26.6 - 53.3 - 69.2 79.9 9 43.3 66.7 11 20.9 27.8 44.1 56.4 68.9 72.6 82.4 13 - - 46.0 - - 71.0 -14 21.8 28.7 - 58.9 - 75.0 83.9 - - 45.9 - - 73.0 -17 22.4 29.3 - 61.0 74.4 76.5 84.7 18 47.2 23.1 30.3 47.5 62.4 76.3 78.2 85.0 24.0 31.1 - 64.4 - - -24.8 31.8 49.3 65.8 - - -25.7 32.6 66.8 26.5 33.2 67.8 27.2 33.8 50.6 69.2 80.2 81.1 87.3 60 28.8 35.0 51.7 69.2 81.1 82_0 88.1 Table 23: Shows the percentage of nicotine released from NPR at different timepoints in the presence of varying equivalent of CaCl2.
Evaluation: the result shows that the presence of CaCl2 significantly increases the 5 release of nicotine from NPR. Increasing the amount of CaCl2 result in an increased release of nicotine. The presence of CaCl2 increases both the initial release rate and seems to also increase the effective release of nicotine.
Example 6C: Release experiment using NPR and varying equivalents of MgC12.
10 The release experiment was performed by adding NPR (16%) and varying equivalents of MgCl2 to a volume of water corresponding to a nicotine concentration of 28 mg/L.

PCT/D1(2021/050334 The equivalents of MgC12 are relative to nicotine. The temperature of the water was 25 degrees Celsius throughout the experiment and stirring of 100 rpm was applied throughout the experiment. pH was measured at experiment start and end. The pH
was in all experiments below 7.0 at both the start and end of the experiment.
A relative low nicotine concentration is used in order to reduce the impact of equilibrium on both the release rate and effective release of nicotine from the ion-exchange resin.
Samples were taken out at varying timepoints and analyzed for nicotine content using standard HPLC. The result is presented as percentage of nicotine released.
0.25 0.75 MgCl2 0 eq 0.1 eq 0.5 eq 1 eq 2 eq 4 eq eq eq Minute Released nicotine (/0) 1 12.4 16.8 23.2 33.7 40.6 42.3 53.7 63.0 3 22.9 32.2 44.1 52.2 55.3 66.5 73.6 5 25.8 37.0 49.9 58.1 62.4 72.2 79.4 7 27.6 39.9 54.0 62.4 66.7 74.8 81.3 9 28.4 41.6 56.7 64.8 69.3 76.5 83.2 11 20.9 29.1 43.0 58.6 67.5 71.7 78.2 83.9 13 29.9 44.5 60.2 70.1 73.0 79.7 85.1 30.5 44.8 61.6 71.2 74.2 80.4 87.0 23.1 31.5 47.2 64.5 72.8 76.5 82.1 87.5 24.0 32.5 47.7 65.7 75.8 77.7 83.8 87.9 24.8 33.2 48.8 68.1 78.2 88.1 Table 24: Shows the percentage of nicotine released from NPR at different timepoints in the presence of varying equivalents of MgCl2.
Evaluation: the result shows that the presence of MgCl2 significantly increases the 15 release of nicotine from NPR. Increasing the amount of MgCl2 result in an increased release of nicotine. The presence of MgCl2 increases both the initial release rate and PCT/D1(2021/050334 seems to also increase the effective release of nicotine. The results are comparable to the result presented in example 6B.
Example 6D: Release experiment using 1 equivalent of CaCl2 and nicotine premix having varying content of nicotine.
The release experiment was performed by adding nicotine premix having varying content of nicotine and 1 equivalent of CaCl2 to a volume of water, whereby a corresponding nicotine concentration of 28 mg/L is obtained. The equivalent of CaCl2 is relative to nicotine. rt he temperature of the water was 25 degrees Celsius throughout the experiment and stirring of 150 rpm was applied throughout the experiment.
pH was measured at experiment start and end. The pH was in all experiments below 7.0 at both the start and end of the experiment.
A relative low nicotine concentration is used in order to reduce the impact of equilibrium on both the release rate and effective release of nicotine from the ion-exchange resin.
Samples were taken out at varying timepoints and analyzed for nicotine content using standard HPLC. The result is presented as percentage of nicotine released.
Ingredients Premix II
II VI VI VII VII VIII VIII
CaCl2 1 eq. 1 eq. 1 eq.
1 eq.
Min. Released nicotine (/o) 1 2.1 9.1 37.2 56.3 43.8 55.7 58.3 69.6 2 3.0 14.7 44.9 66.9 53.4 66.0 66.2 78.7 3 4.0 19.9 48.9 71.4 57.4 73.4 70.1 82.6 4 4.9 24.7 51.8 76.8 60.1 77.8 72.0 85.9 5 5.7 29.8 53.7 79.5. 62.2 81.4 73.0 88.4 6 6.5 33.7 54.4 81.6 63.0 84.1 74.7 90.3 7 7.1 38.6 55.4 83.1 64.4 86.2 75.0 92.3 8 8.0 42.0 56.1 84.8 65.2 88.9 75.4 92.9 PCT/D1(2021/050334 9 8.4 46.4 56.9 86.3 65.5 90.5 75.7 94.5 10 9.0 49.9 57.4 87.3 66.1 91.1 76.0 94.7 11 53.1 58.0 88.0 66.5 92.6 76.5 95.7 12 55.6 58.4 89.2 67.3 93.4 96.3 13 57.7 58.5 89.9 66.9 93.8 77.0 96.9 14 60.5 58.9 90.9 67.3 95.0 97.3 15 11.8 62.0 59.6 91.6 68.2 95.8 77.3 97.3 Table 25: Shows the percentage of nicotine released from nicotine premix at different timepoints in the presence of 1 equivalent of MgCl2.
Evaluation: the result shows that the presence of CaCl2 significantly increases the 5 release of nicotine from premixes. The presence of CaC12 increases both the initial release rate and seems to also increase the effective release of nicotine.
Furthermore, the results demonstrate that increasing the nicotine content of the premixes also increases the nicotine release.
Example 6E: Release experiment using 1 equivalent of A1C13.
The release experiment was performed by adding NPR (16%) and 1 equivalent of A1C13 to a volume of water corresponding to a nicotine concentration of 28 mg/L. The equivalents are relative to nicotine. The temperature of the water was 25 degrees Celsius throughout the experiment and stirring of 150 rpm was applied throughout the experiment. pH was measured at experiment start and end. The pH was in all experiments below 7.0 at both the start and end of the experiment.
A relative low nicotine concentration is used in order to reduce the impact of equilibrium on both the release rate and effective release of nicotine from the ion-exchange resin.
Samples were taken out at varying timepoints and analyzed for nicotine content using standard HPLC. The result is presented as percentage of nicotine released.

PCT/D1(2021/050334 No 1 eq Salt Salt AlC13 Released Minutes nicotine (3/0) 1 11.1 39.9 3 14.5 49.4
16.1 55.4 8 18.2 60.9 11 19.7 64.4 20.0 68.4 21.1 71.4 21.5 74.0 22.4 75.4 Table 24: Shows the percentage of nicotine released from NPR at different timepoints in the presence of 1 equivalent of A1C13.
Evaluation: the results demonstrate that the presence of 1 equivalent of AlC13 5 significantly increases the release of nicotine from NPR. The presence of A1C13 increases both the initial release rate and seems to also increase the effective release of nicotine.
Example 7A: Pouch release experiments (in vitro) 10 The release properties of the pouches were tested in an in vitro experiment.
Reaction tubes having a diameter approx. 2 cm and containing 10 mL of 0.02 M
potassium dihydrogen phosphate-buffer (pH adjusted to 7.4) were warmed to 37 degrees Celsius. One reaction tuber per timepoint was used.
A pouch was submerged in the buffer of the first reaction tube using tweezers.
After a 15 specified time period, the pouch was captured with the tweezer and gently swirled in the buffer before being removed from the first reaction tube and added to the next reaction tube, representing the next time point. The procedure was repeated until the desired number of time points had been tested.

PCT/D1(2021/050334 The whole release experiment was performed at 37 degrees Celsius. No stirring or shaken was applied during the release experiment.
The amount of release nicotine was determined by analyzing the buffer samples at the different timepoints using standard HPLC.
Example 8A: Release experiment on pouches The release experiment was performed as described in example 7A.
Pouch C4 P40 P42 CS P43 P45 Premix II II II VI VI VI
CaCl2 - 0.75 eq 1.5 eq - 0.75 eq 1.5 eq NaCl 2.9 eq - - 2.9 eq -Min. Released nicotine (/o) 2 13.8 12.9 32.4 20.8 24.0 39.3 5 25.7 26.0 49.6 39.8 42.9 62.5 10 37.5 40.3 66.0 59.0 61.7 78.8 30 60.4 62.3 79.9 79.4 82.6 90.3 Table 27A: Shows the percentage of nicotine released from nicotine pouches at different timepoints in the presence of varying equivalents of CaCl2.
Pouch C10 P110 C11 P113 C12 P116 P117 Premix II II VI VI II II II
0.75 0.75 CaCl2 2.0 eq 5.0 eq eq eq NaCl Min. Released nicotine (/0) 2 16.2 29.5 26.9 38.7 22.1 26.4 35.4 5 28.6 50.9 47.4 58.2 36.3 40.2 55.5 10 42.0 64.8 66.0 74.8 52.1 56.0 77.2 PCT/D1(2021/050334 30 59.2 78.7 79.5 92.2 73.7 82.1 99.2 Table 27B: Shows the percentage of nicotine released from nicotine pouches at different timepoints in the presence of varying equivalents of CaCl2.
Evaluation: comparing P110 and P113 with C10 and C11 respectively, the result shows that the presence of CaCl2 increases the release of nicotine from pouches. This is also confirmed by comparison of P116 with C12. The presence of CaCl2 increases both the initial release rate and seems to also increase the effective release of nicotine.
Comparing P40 and P42, and comparing P116 and P117, demonstrate that increasing the amount of CaCl2 in a pouch also increases the nicotine release from the pouch.
Also, it is noted that desirable improved release results are demonstrated to be obtained with various formulations including different fibers, here wheat fiber and powdered cellulose.
Furthermore, the results demonstrate that increasing the nicotine content of the premixes also increases the nicotine release from the pouches, comparing P40 with P43, P42 with P45 and P110 with P113.
Finally, it is noted that in order to obtain a release being comparable to the release obtained from pouches comprising only 0.75 eq CaCl2, a much higher amount of NaCl will be needed, here at least 2.9 eq NaCl required to obtain a release being comparable to 0.75 eq CaCl2 (see C4, C5, P40 and P43).
Example 9A: User evaluation.
The produced pouches of the invention were evaluated and found highly suitable as delivery vehicles of nicotine in that they provide a favorable release of nicotine and at the same time are pleasant to the user, e.g. with respect to a desirable mouthfeel such as a moist and moldable texture and a desirable taste.
Example 9B: User evaluation.
The pouch products P03, P44 and P117 were evaluated with respect to perceived effect from nicotine and mouthfeel.

PCT/D1(2021/050334 Evaluation of perceived effect from nicotine and mouthfeel is performed as described in the following.
Perceived effect from nicotine and mouthfeel was evaluated by a test panel of 4 trained assessors. Each assessor evaluates all samples twice. Average evaluations are estimated.
The pouch product P03,P44 and P117 were evaluated to have a fast onset of action and a high perceived effect from nicotine by all four assessors. Also, all four assessors evaluated the pouch products to have a desirable mouthfeel, i.e. the pouches were found to be moist and have a desirable taste.
Similarly, the pouches, P08 and P127, were evaluated. These pouches were evaluated to have a fast onset of action and a high perceived effect from nicotine by all four assessors. However, the pouches were found to provide a less desirable mouthfeel, the pouches being perceived as somewhat dry, adhering to the oral mucosa and/or as having a poor taste or less desirable taste, i.e. too salty.
Pouches comparable to P127 but comprising higher amounts of flavor, were also evaluated, i.e. P128 and P129. Despite their increased flavor levels compared to P127, these pouches were also perceived as being dry and adhering to the oral mucosa.
Furthermore, the taste was also for these pouches found to be less desirable, as notes of saltiness were still perceived and the flavor profile was perceived as imbalanced.
These observations indicate that the less desirable mouth feel and taste effects associated with high levels of inorganic divalent cations cannot be offset by increasing the level of flavor in the pouch composition. I.e. simple taste masking by means of high flavor levels cannot offset undesirable effects encountered at high levels of inorganic divalent cations.

Claims (63)

PCT/DK2021/050334
1. A pouch composition comprising a nicotine-ion exchange resin combination, 5 water in an amount of at least 15% by weight of the pouch composition, and inorganic divalent cations.
2. The pouch composition according to claim 1, wherein the pouch composition comprises inorganic divalent cations in molar ratio of at least 0.1 relative 10 to the amount of nicotine in the nicotine-ion exchange resin combination, such as at least 0.25 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at least 0.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
15 3. The pouch composition according to claim 1 or 2, wherein the pouch composition comprises inorganic divalent cations in a molar ratio of at most 6.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 6 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 5 relative to the amount of nicotine in the nicotine-ion 20 exchange resin combination, such as at most 3.75 relative to the amount of nicotine in the nicotine-ion exchange resin combination, such as at most 2.5 relative to the amount of nicotine in the nicotine-ion exchange resin combination.
4. The pouch composition according to any of claims 1-3, wherein the inorganic 25 divalent cations are selected from the group consisting of divalent cations of calcium, magnesium, iron, zinc, and any combination thereof
5. The pouch composition according to any of claims 1-4, wherein the inorganic divalent cations are selected from the group consisting of divalent cations of calcium 30 and magnesium.
6. The pouch composition according to any of claims 1-5, wherein the inorganic divalent cations are provided as a salt comprising anions selected from the group consisting of carboxylates, such as acetate, lactate, oxalate, propionate, or levulinate;
organic sulfonate; organic sulfate; organic phosphate; chloride, bromide, nitrate, sulfate, hydrogen phosphate, oxide, and any combination thereof.
7. The pouch composition according to any of claims 1-6, wherein the inorganic divalent cations are provided as an inorganic salt.
8. The pouch composition according to any of claims 1-7, wherein the inorganic divalent cations are provided as a salt in an amount of between 0.1 and 15.0%
by weight of the composition, such as between 0.1 and 10.0% by weight of the composition, such as between 0.5 and 10.0% by weight of the composition.
9. The pouch composition according to any of claims 1-8, wherein the inorganic divalent cations are provided as an inorganic salt comprising inorganic anions selected from the group consisting of chloride, bromide, nitrate, sulfate, hydrogen carbonate, hydrogen phosphate, oxide, hydroxide, and any combination thereof
10. The pouch composition according to any of claims 1-9, wherein the inorganic divalent cations are provided as an inorganic salt comprising inorganic anions selected from the group consisting of chloride, bromide, hydrogen carbonate, sulfate, and any combination thereof.
11. The pouch composition according to any of claims 1-10, wherein the inorganic divalent cations are provided as an inorganic salt comprising inorganic anions are selected from the group consisting of chloride, bromide, and any combination thereof.
12. The pouch composition according to any of claims 1-11, wherein the inorganic anions comprise chloride.
13. The pouch composition according to any of claims 1-12, wherein the inorganic divalent cations are provided as an inorganic salt selected from the group consisting of calcium chloride or magnesium chloride, or combinations thereof
14. The pouch composition according to any of claims 1-13, wherein the divalent cations are provided as a water-soluble salt having a water-solubility of at least 5 gram per 100 mL of water measured at 25 degrees Celsius, atmospheric pressure and pH
15. The pouch composition according to any of claims 1-14, wherein the pouch composition comprises nicotine in an amount of at least 0.1% by weight, such as least 0.2% by weight of the pouch composition.
16. The pouch composition according to any of claims 1-15, wherein the pouch composition comprises nicotine-ion exchange combination in an amount of 0.1 to 20%
by weight of the pouch composition.
17. The pouch composition according to any of claims 1-16, wherein the nicotine-ion exchange resin combination comprises nicotine in an amount of between 5 and 50 A
by weight.
18. The pouch composition according to any of claims 1-17, wherein the nicotine-ion exchange resin combination comprises nicotine in an amount of between 5 and 50%
by weight and ion-exchange resin in an amount between 10 and 95% by weight.
19. The pouch composition according to any of claims 1-18, wherein the ion exchange resin comprises one or more resin(s) selected from the group consisting of:
(i) a methacrylic, weakly acidic type of resin containing carboxylic functional groups, (ii) a copolymer of methacrylic acid and divinylbenzene, said copolymer containing carboxylic functional groups, (iii) a polystyrene, strongly acidic type of resin containing sulphonic functional groups, (iv) a polystyrene, intermediate acidic type of resin containing phosphonic functional groups, and (v) a combination thereof.
20. The pouch composition according to any of claims 1-19, wherein the ion exchange resin comprises polacrilex resin.
21. The pouch composition according to any of claims 1-20, wherein the ion exchange resin is polacrilex resin.
22. The pouch composition according to any of claims 1-21, wherein the nicotine-ion exchange resin combination comprises nicotine complexed with ion exchange resin.
23. The pouch composition according to any of claims 1-22, wherein the nicotine-ion exchange resin combination is nicotine complexed with ion exchange resin.
24. The pouch composition according to any of claims 1-23, wherein the nicotine-ion exchange resin combination comprises free-base nicotine mixed with ion exchange resin.
25. The pouch composition according to any of claims 1-24, wherein the pouch composition comprises water in an amount of 15-65% by weight of the composition, such as 15-60% by weight of the composition, such as 15-50% by weight of the composition, such as 20-50% by weight of the composition, such as 20-40% by weight of the composition, such as 25-40% by weight of the composition, such as 25-35% %
by weight of the composition.
26. The pouch composition according to any of claims 1-25, wherein the pouch composition comprises at least one sugar alcohol.
27. The pouch composition according to any of claims 1-26, wherein the at least one sugar alcohol is selected frorn xylitol, maltitol, mannitol, erythritol, isomalt, sorbitol, lactitol, and mixtures thereof.
28. The pouch composition according to any of claims 1-27, wherein the pouch composition comprises at least two sugar alcohols.
29. The pouch composition according to any of claims 1-28, wherein the pouch composition comprises sugar alcohol in an amount of at least 1% by weight of the composition, such as at least 2% by weight of the composition, such as at least 5% by weight of the composition, such as at least 10% by weight of the composition, such as at least 15% by weight of the composition.
30. The pouch composition according to any of claims 1-29, wherein the pouch composition comprises sugar alcohol in an amount of 1 to 80% by weight of the composition, such as 2 to 70% by weight of the composition, such as 5 to 60%
by weight of the composition, such as 10 to 50% by weight of the composition, such as 15 to 50% by weight of the composition.
31. The pouch composition according to any of claims 1-30, wherein the pouch composition compri ses at least one water-insoluble fiber.
32. The pouch composition according to any of claims 1-31, wherein the pouch composition comprises said water-insoluble fiber in an amount between 5 and 50 %
by weight of the pouch composition, such as 10-45% by weight of the pouch composition, such as 15-40% by weight of the pouch composition.
33. The pouch composition according to any of claims 1-32, wherein the water-insoluble fiber is a plant fiber.
34. The pouch composition according to any of claims 1-33, wherein the water-insoluble fiber is selected from wheat fibers, pea fibers, rice fiber, maize fibers, oat fibers, tomato fibers, barley fibers, rye fibers, sugar beet fibers, buckwheat fibers, potato fibers, cellulose fibers, apple fibers, cocoa fibers, cellulose fibers, bran fibers, bamboo fibers, powdered cellulose, and combinations thereof.
35. The pouch composition according to any of claims 1-34, wherein the water-insoluble fiber has a water binding capacity of at least 200%, such as at least 300%, such as at least 400%.
36. The pouch composition according to any of claims 1-35, wherein the water-insoluble fiber has a density of 50 to 500 gram per Liter, such as 100 to 400 gram per Liter, such as 200 to 300 gram per Liter.
37. The pouch composition according to any of claims 1-36, wherein the pouch composition comprises a pH regulating agent.
38. The pouch composition according to any of claims 1-37, wherein the pouch composition comprises pH regulating agent in an amount between 0.01 and 15% by weight of the pouch composition, such as between 0.5 and 10% by weight of the pouch composition, such as between 1 and 10% by weight of the pouch composition, such as between 5 and 10% by weight of the pouch composition.
39. The pouch composition according to any of claims 1-38, wherein the pH
regulating agent is a basic pH regulating agent, such as a basic buffering agent.
40. The pouch composition according to any of claims 1-39, wherein the pH
regulating agent is a buffering agent, such as a basic buffering agent.
41. The pouch composition according to any of claims 1-40, wherein the pH
regulating agent is selected from the group consisting Sodium carbonate, Sodium bicarbonate, Potassium carbonate, and Magnesium carbonate; Potassium bicarbonate;
trometamol;
phosphate buffer, amino acids, or any combination thereof
42. The pouch composition according to any of claims 1-41, wherein the pH
regulating agent is selected from the group consisting Sodium carbonate, Sodium bicarbonate, Potassium carbonate, and Magnesium carbonate; Potassium bicarbonate;
trometamol;
phosphate buffer, or any combination thereof
43. rrhe pouch composition according to any of claims 1-42, wherein the pH
regulating agent is selected from the group consisting of trometamol, amino acids and phosphate buffer, or any combination thereof
44. The pouch composition according to any of claims 1-43, wherein the pH
regulating agent is selected from the group consisting of trometamol and phosphate buffer, or any combination thereof.
45. The pouch composition according to any of claims 1-44, wherein the pH
adjusting agent is trometamol.
46. The pouch composition according to any of claims 1-44, wherein the pH
adjusting agent is phosphate buffer.
47. The pouch composition according to any of claims 1-43, wherein the pH
adjusting agent is amino acid.
48. The pouch composition according to any of claims 1-47, wherein the pouch composition is adapted to release at least 30% nicotine within 10 minutes when exposed to in vitro conditions described in example 7A.
49. The pouch composition according to any of claims 1-48, wherein the pouch composition is adapted to release at least 25% more nicotine within 5 minutes compared to a corresponding pouch composition without divalent cations when exposed to in vitro conditions described in example 7A.
50. The pouch composition according to any of claims 1-49, wherein the pouch composition comprises humectant.
51. The pouch composition according to any of claims 1-50, wherein the pouch composition comprises sodium chloride in an amount of 0.0-3.0% by weight of the pouch compositions, such as 0.05 ¨ 1.00A by weight of the pouch composition, such as 0.1 ¨ 1.0% by weight of the pouch composition.
52. The pouch composition according to any of claims 1-51, wherein the pouch composition is a non-tobacco pouch composition.
53. The pouch composition according to any of claims 1-51, wherein the pouch composition comprises less than 2.0% by weight of tobacco, such as less than 1.00A
by weight of tobacco, such as less than 0.5% by weight of tobacco, such as 0.0% by weight of tobacco.
54. The pouch composition according to any of claims 1-51, wherein the pouch composition comprises a non-tobacco fiber.
55. The pouch composition according to any of claims 1-54, wherein the pouch composition is a powdered composition.
56. An oral pouched nicotine product comprising a saliva-permeable pouch and the pouch composition of any of claims 1 ¨ 55 enclosed in said pouch.
57. The oral pouched nicotine product according to claim 56, wherein the pouched nicotine product comprises nicotine in an amount of 0.5 to 20 mg, such as 1.0 to 20 mg, such as 5.0 to 15 mg.
58. The oral pouched nicotine product according to claim 56 or 57, wherein the pouched nicotine product comprises nicotine-ion exchange combination in an amount of 1 to 100 mg per pouch.
59. A pouch composition comprising a nicotine-ion exchange resin combination, and inorganic multivalent cations.
60. The pouch composition according to claim 59, wherein said multivalent cations are selected from the group consisting of multivalent ions of calcium, magnesium, zinc, aluminum, barium, iron, manganese, copper, lead, cobalt, nickel, such as Ca2+, Mg2+, Zn2+, A13+, Ba2+, Fe2+, Fe3+, Fe4+, Mn2+, Mn4+, Cu4+, or any combinations thereof
61. The pouch composition according to claim 59 or 60, wherein the multivalent cations are trivalent.
62. The pouch composition according to claim 59-61, wherein the multivalent cations are selected from the group consisting of trivalent cations of aluminum, divalent cations of calcium, magnesium, iron, zinc, and any combination thereof
63. The pouch composition according to any of claims 59-60 or 62 wherein the multivalent cations are selected from the group consisting of divalent cations of calcium, magnesium, iron, zinc, and any combination thereof
CA3198533A 2020-11-16 2021-11-16 Nicotine pouch composition Pending CA3198533A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP20207822.6A EP4000424B1 (en) 2020-11-16 2020-11-16 Nicotine pouch composition
US17/099,446 US20220151292A1 (en) 2020-11-16 2020-11-16 Nicotine pouch composition
EP20207822.6 2020-11-16
US17/099,446 2020-11-16
PCT/DK2021/050334 WO2022100805A1 (en) 2020-11-16 2021-11-16 Nicotine pouch composition

Publications (1)

Publication Number Publication Date
CA3198533A1 true CA3198533A1 (en) 2022-05-19

Family

ID=78676251

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3198533A Pending CA3198533A1 (en) 2020-11-16 2021-11-16 Nicotine pouch composition

Country Status (4)

Country Link
JP (1) JP2023549345A (en)
CN (1) CN116419682A (en)
CA (1) CA3198533A1 (en)
WO (1) WO2022100805A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023106407A1 (en) * 2021-12-09 2023-06-15 日本たばこ産業株式会社 Composition for oral cavity and pouch product for oral cavity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2754412C2 (en) * 2017-04-24 2021-09-02 Свидиш Мэтч Норт Юроп Аб Flavored wet oral packaged nicotine product containing triglyceride
WO2018233795A1 (en) * 2017-06-23 2018-12-27 Fertin Pharma A/S Nicotine pouch
WO2020157280A1 (en) * 2019-02-01 2020-08-06 Swedish Match North Europe Ab AN ORAL NICOTINE PRODUCT COMPRISING A pH ADJUSTING AGENT

Also Published As

Publication number Publication date
JP2023549345A (en) 2023-11-24
CN116419682A (en) 2023-07-11
WO2022100805A1 (en) 2022-05-19

Similar Documents

Publication Publication Date Title
US11096412B2 (en) Nicotine pouch composition and pouch comprising such
US11406630B2 (en) Nicotine pouch
US11963944B2 (en) Cannabinoid pouch
DK180339B1 (en) Nicotine pouch composition and pouch comprising such
US20200179329A1 (en) Cannabinoid Pouch
CA3198533A1 (en) Nicotine pouch composition
EP4000424B1 (en) Nicotine pouch composition
US20220151292A1 (en) Nicotine pouch composition